
<html lang="en"     class="pb-page"  data-request-id="1d1f5240-824a-4180-82a3-c39b719d3f2a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm200695m;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Biological Evaluation of 3-(1H-Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26)" /></meta><meta name="dc.Creator" content="Mohamed S.  Gomaa" /></meta><meta name="dc.Creator" content="Caroline E.  Bridgens" /></meta><meta name="dc.Creator" content="Gareth J.  Veal" /></meta><meta name="dc.Creator" content="Christopher P. F.  Redfern" /></meta><meta name="dc.Creator" content="Andrea  Brancale" /></meta><meta name="dc.Creator" content="Jane L.  Armstrong" /></meta><meta name="dc.Creator" content="Claire  Simons" /></meta><meta name="dc.Description" content="The synthesis and potent inhibitory activity of novel 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propyl derivatives vs a MCF-7 CYP26A1 microsomal assay is desc..." /></meta><meta name="Description" content="The synthesis and potent inhibitory activity of novel 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propyl derivatives vs a MCF-7 CYP26A1 microsomal assay is desc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 8, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200695m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200695m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200695m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200695m" /></link>
        
    
    

<title>Synthesis and Biological Evaluation of 3-(1H-Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200695m" /></meta><meta property="og:title" content="Synthesis and Biological Evaluation of 3-(1H-Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0007.jpeg" /></meta><meta property="og:description" content="The synthesis and potent inhibitory activity of novel 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propyl derivatives vs a MCF-7 CYP26A1 microsomal assay is described. This study focused on the effect of modifying the heme binding azole group and the flexible C3 chain on inhibitory activity and selectivity. The most promising inhibitor 2,2-dimethyl-3-[4-(naphthalen-2-ylamino)-phenyl]-3-[1,2,4]triazol-1-yl-propionic acid methyl ester (17) (IC50 = 0.35 nM as compared with liarozole IC50 = 540 nM and R116010 IC50 = 10 nM) was evaluated for CYP selectivity and hepatic stability. Compounds with CYP26 inhibitory IC50 values ≤50 nM enhanced the biological activity of exogenous ATRA, as evidenced by a 3.7–5.8-fold increase in CYP26A1 mRNA in SH-SY5Y neuroblastoma cells as compared with ATRA alone. All compounds demonstrated an activity comparable with or better than R116010, and the induction correlated well with CYP26 inhibition data. These studies highlight the promising activity profile of this novel CYP26 inhibitor and suggest it as an appropriate candidate for future development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200695m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200695m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200695m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200695m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200695m&amp;href=/doi/10.1021/jm200695m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 6803-6811</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200694q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200723m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Evaluation of 3-(1<i>H</i>-Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed+S.++Gomaa">Mohamed S. Gomaa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline+E.++Bridgens">Caroline E. Bridgens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gareth+J.++Veal">Gareth J. Veal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+P.+F.++Redfern">Christopher P. F. Redfern</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Brancale">Andrea Brancale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+L.++Armstrong">Jane L. Armstrong</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Simons">Claire Simons</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-text"><sup>‡</sup>Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, and <sup>§</sup>Institute of Cellular Medicine, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom</span></div><div class="corresp-info">Tel: +44(0)191-222 5644. Fax: +44(0)191-222 7179. E-mail: <a href="/cdn-cgi/l/email-protection#9ef4b0f2b0ffecf3edeaecf1f0f9def0fbe9fdffedeaf2fbb0fffdb0ebf5"><span class="__cf_email__" data-cfemail="6802460446091a051b1c1a07060f28060d1f0b091b1c040d46090b461d03">[email protected]</span></a> (J.L.A.). Tel: +44(0)2920-876307. Fax: +44(0)2920-874149. E-mail: <a href="/cdn-cgi/l/email-protection#3d6e545052534e7e7d7e5c4f59545b5b135c5e134856"><span class="__cf_email__" data-cfemail="6d3e040002031e2e2d2e0c1f09040b0b430c0e431806">[email protected]</span></a> (C.S.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200695m&amp;href=/doi/10.1021%2Fjm200695m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 6803–6811</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 15, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 June 2011</li><li><span class="item_label"><b>Published</b> online</span>8 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200695m" title="DOI URL">https://doi.org/10.1021/jm200695m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6803%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMohamed%2BS.%2BGomaa%252C%2BCaroline%2BE.%2BBridgens%252C%2BGareth%2BJ.%2BVeal%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D19%26contentID%3Djm200695m%26title%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2B3-%25281H-Imidazol-%2Band%2BTriazol-1-yl%2529-2%252C2-dimethyl-3-%255B4-%2528naphthalen-2-ylamino%2529phenyl%255Dpropyl%2BDerivatives%2Bas%2BSmall%2BMolecule%2BInhibitors%2Bof%2BRetinoic%2BAcid%2B4-Hydroxylase%2B%2528CYP26%2529%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6811%26publicationDate%3DOctober%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200695m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1084</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200695m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Evaluation of 3-(1H-Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;S. Gomaa&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;E. Bridgens&quot;},{&quot;first_name&quot;:&quot;Gareth&quot;,&quot;last_name&quot;:&quot;J. Veal&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;P. F. Redfern&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Brancale&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;L. Armstrong&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Simons&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;6803-6811&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200695m&quot;},&quot;abstract&quot;:&quot;The synthesis and potent inhibitory activity of novel 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propyl derivatives vs a MCF-7 CYP26A1 microsomal assay is described. This study focused on the effect of modifying the heme binding azole group and the flexible C3 chain on inhibitory activity and selectivity. The most promising inhibitor 2,2-dimethyl-3-[4-(naphthalen-2-ylamino)-phenyl]-3-[1,2,4]triazol-1-yl-propionic acid methyl ester (17) (IC50 = 0.35 nM as compared with liarozole IC50 = 540 nM and R116010 IC50 = 10 nM) was evaluated for CYP selectivity and hepatic stability. Compounds with CYP26 inhibitory IC50 values ≤50 nM enhanced the biological activity of exogenous ATRA, as evidenced by a 3.7–5.8-fold increase in CYP26A1 mRNA in SH-SY5Y neuroblastoma cells as compared with ATRA alone. All compounds demonstrated an activity comparable with or better than R116010, and the induction correlated well with CYP26 inhibition data. These studies highlight the promising activity&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200695m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200695m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200695m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200695m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200695m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200695m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200695m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200695m&amp;href=/doi/10.1021/jm200695m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200695m" /></input><a href="/doi/pdf/10.1021/jm200695m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200695m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200695m%26sid%3Dliteratum%253Aachs%26pmid%3D21838328%26genre%3Darticle%26aulast%3DGomaa%26date%3D2011%26atitle%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2B3-%25281H-Imidazol-%2Band%2BTriazol-1-yl%2529-2%252C2-dimethyl-3-%255B4-%2528naphthalen-2-ylamino%2529phenyl%255Dpropyl%2BDerivatives%2Bas%2BSmall%2BMolecule%2BInhibitors%2Bof%2BRetinoic%2BAcid%2B4-Hydroxylase%2B%2528CYP26%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D19%26spage%3D6803%26epage%3D6811%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291783" title="Triazole">Triazole</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=292253" title="Imidazoles">Imidazoles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jmcmar.2011.54.issue-19/production/jmcmar.2011.54.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and potent inhibitory activity of novel 3-(1<i>H</i>-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propyl derivatives vs a MCF-7 CYP26A1 microsomal assay is described. This study focused on the effect of modifying the heme binding azole group and the flexible C3 chain on inhibitory activity and selectivity. The most promising inhibitor 2,2-dimethyl-3-[4-(naphthalen-2-ylamino)-phenyl]-3-[1,2,4]triazol-1-yl-propionic acid methyl ester (<b>17</b>) (IC<sub>50</sub> = 0.35 nM as compared with liarozole IC<sub>50</sub> = 540 nM and R116010 IC<sub>50</sub> = 10 nM) was evaluated for CYP selectivity and hepatic stability. Compounds with CYP26 inhibitory IC<sub>50</sub> values ≤50 nM enhanced the biological activity of exogenous ATRA, as evidenced by a 3.7–5.8-fold increase in CYP26A1 mRNA in SH-SY5Y neuroblastoma cells as compared with ATRA alone. All compounds demonstrated an activity comparable with or better than R116010, and the induction correlated well with CYP26 inhibition data. These studies highlight the promising activity profile of this novel CYP26 inhibitor and suggest it as an appropriate candidate for future development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Retinoic acid (RA) is a naturally occurring retinoid, the main biologically active derivative of vitamin A (retinol), which regulates cell growth and differentiation in a variety of cell types. As a key signaling molecule, the intracellular concentrations of RA are regulated by negative feedback controls tightly coupled to requirements for signaling in relation to cell differentiation and morphogenesis.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Retinoids have long been major drugs used to treat disorders of keratinization such as acne, psoriasis, and ichthyosis<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3-6)</a> and have been successful in the treatment of acute promyelocytic leukemia<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and neuroblastoma.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Unfortunately, natural and induced resistance to RA as well as local and systemic toxicity limit the potential of RA in the treatment of these diseases and as a therapeutic strategy for a wider range of diseases.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">One approach to overcoming drug resistance is to increase intracellular RA concentrations through inhibition of RA catabolic enzymes. The major enzyme responsible for RA metabolism is the RA-inducible cytochrome P450 (CYP) enzyme, CYP26.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> CYP26 therefore provides a good target for the development of RA metabolism blocking agents (RAMBAs) to improve efficacy of retinoid treatment. Reducing the rate of metabolism of RA using RAMBAs that can be cleared from the body on cessation of therapy may reduce the unwanted side effects associated with high-dose RA treatment.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">Two RAMBAs have been developed clinically, the azoles liarozole and talarozole (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), both for dermatological treatment. In humans, topical application of liarozole exhibits similar clinical effects to the RA analogue acitretin but with fewer side effects.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, it lacks CYP26 specificity and inhibits steroidogenic CYP enzymes including aromatase (CYP19).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In humans, talarozole (formerly R115866 and Rambazole) exhibits beneficial effects in both psoriasis<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and acne,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and the side effects are expected to be less severe as compared with previous synthetic retinoids.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><i>N</i>-(4-((1<i>R</i>,2<i>R</i>)-2-(Dimethylamino)-1-(1<i>H</i>-imidazol-1-yl)propyl)phenyl)benzo[<i>d</i>]thiazol-2-amine (R116010)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a potent and selective inhibitor of RA metabolism, which inhibits all-<i>trans</i>-retinoic acid (ATRA) metabolism in neuroblastoma both in vitro and in vivo,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> although there are no further details regarding the clinical development of this RAMBA.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RAMBAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In previous studies,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we reported the development of the lead CYP26 inhibitor, <i>N</i>-(4-((1<i>H</i>-imidazol-1-yl)(phenyl)methyl)phenyl)naphthalen-2-amine (<b>1</b>) (IC<sub>50</sub> = 0.5 μM; as compared with Liarozole, IC<sub>50</sub> = 540 nM, and R116010, IC<sub>50</sub> = 10 nM) by modification of the aryl, NH linker, and phenyl to a C3 chain (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> These studies indicated that a broad range of aryl and heteroaryl substituents were tolerated, that the NH linker was optimal with a noted reduction in inhibitory activity if replaced with either an −O– or a −CH<sub>2</sub>– linker, and that the dimethyl group was important in establishing hydrophobic interactions and optimizing “fit” within the CYP26 active site. Several low nanomolar inhibitors were discovered through structure–activity relationship (SAR) studies with methyl 3-(1<i>H</i>-imidazol-1-yl)-2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)propanoate (<b>2</b>) (IC<sub>50</sub> = 3 nM, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) evaluated further for selectivity and hepatic stability. Direct comparison of CYP selectivity profiles for compound <b>2</b> and R116010 revealed markedly reduced activity as compared with CYP26 for CYPs 1A2, 2C9, 2C19, and 2D6. However, both compounds exhibited activity against CYP3A4, a xenobiotic-metabolizing CYP with low substrate specificity and which is known to have activity as an ATRA hydroxylase, with IC<sub>50</sub> values of <0.1 μM for compound <b>2</b> and 0.35 μM for R116010.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development of compounds through SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">CYP3A4 liability will restrict further development of RAMBAs for systemic use, although likely to be less of an issue for topical administration in combination with ATRA; therefore, further SAR studies were required to determine the effect on selectivity and inhibitory activity. The two areas for SAR studies described here are the C3 flexible chain and the heme binding azole (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of several ester and amide analogues of (<b>2</b>) was undertaken. The preparation of the acid (<b>4</b>) was performed through saponification of the lead compound (<b>2</b>) with KOH in EtOH under reflux.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The acid was separated in good yield after acidification of the potassium salt (<b>3</b>) with aqueous 1 N HCl followed by extraction with dichloromethane (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) KOH, EtOH, reflux, 72 h. (ii) 1 N aqueous HCl, 64%. (iii) RBr, DMF, 80 °C, 2 h, 57–71%. (iv) EDC, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, room temperature and then R<sup>1</sup>R<sup>2</sup>NH, room temperature, overnight, 61–75%. (v) LiAlH<sub>4</sub>, THF, 0 °C, 1 h and then room temperature overnight, 79%.</p></p></figure><div class="NLM_p">Several esters (<b>5</b>–<b>9</b>) were prepared by stirring the potassium salt (<b>3</b>) with the corresponding alkyl halides in EtOH at room temperature, with the ester products obtained in good yield after purification by column chromatography (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The amide derivatives (<b>10</b>–<b>13</b>) were prepared through the reaction of the acid (<b>4</b>) with an amine in the presence of EDC and HOBt in dichloromethane<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> and obtained in good yield after purification by flash column chromatography. The alcohol analogue (<b>15</b>) of compound (<b>14</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was generated by reduction with LiAlH<sub>4</sub> in THF<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><div class="NLM_p">The modification of the <i>N</i>-heterocycle moiety involved the preparation of triazole derivatives. The triazole analogue was prepared through the reaction of the alcohol precursor (<b>16</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with 1,1′-carbonylditriazole and triazole in acetonitrile to give the triazole derivative (<b>17</b>) in good yield (63%) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Attempts to prepare the triazole acid (<b>18</b>) derivative following the previously described method for the imidazole acid (<b>4</b>) using KOH and EtOH were unsuccessful with no reaction observed; however, hydrolysis of the triazole ester (<b>17</b>) was accomplished with LiOH in THF and H<sub>2</sub>O.<a onclick="showRef(event, 'ref26 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref28">(26, 28)</a> The acid was obtained in good yield after acidification (pH 3) and extraction with diethyl ether and used without further purification. The triazole amide derivative (<b>19</b>) was obtained after treatment of the acid (<b>18</b>) with methylamine in the presence of EDC and HOBt in dichloromethane (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1,1′-Carbonylditriazole, triazole, CH<sub>3</sub>CN, reflux, 16 h, 63%. (ii) LiOH, THF, H<sub>2</sub>O, 20 h, reflux and then (iii) aqueous 1 N HCl 77%. (iv) EDC, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, room temperature and then CH<sub>3</sub>NH<sub>2</sub>, room temperature, overnight, 63%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Enzyme Inhibition</h3><div class="NLM_p">The imidazole and triazole derivatives were evaluated for their RA metabolism (CYP26) inhibitory activity with a cell-free microsomal assay,<a onclick="showRef(event, 'ref23 ref29'); return false;" href="javascript:void(0);" class="ref ref23 ref29">(23, 29)</a> using radiolabeled [11,12-<sup>3</sup>H]ATRA as the substrate. Liarozole (a nonselective CYP26 inhibitor<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a>) and R116010<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were included in all experiments as comparative standards.</div><div class="NLM_p">In the ester series (<b>2</b> and <b>5</b>–<b>9</b>), a small alkyl substituent was optimal with the methyl ester (<b>2</b>, IC<sub>50</sub> = 3 nM) and ethyl ester (<b>5</b>, IC<sub>50</sub> = 0.35 nM) being preferred as compared with larger chains such as butyl (<b>6</b>) and pentyl (<b>7</b>) (IC<sub>50</sub> = 200 and 140 nM, respectively), branched isopropyl (<b>8</b>, IC<sub>50</sub> = 290 nM), and the bulky aromatic benzyl ester (<b>9</b>, IC<sub>50</sub> = 400 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It is probable that the enhanced inhibitory activity observed for the ethyl ester (<b>5</b>) is related to pharmacodynamic properties rather than enhanced binding, whereas for the larger alkyl esters a reduced fit has a direct impact on inhibitory activity. Replacing the ester with an amide (<b>10</b>–<b>13</b>) was generally well tolerated (IC<sub>50</sub> range = 12–120 nM) with the methyl amide isostere (<b>11</b>) of the lead methyl ester (<b>2</b>) displaying comparable inhibitory activity with an IC<sub>50</sub> of 12 nM. The order of preference for inhibitory activity of the amides was NHMe > NH<sub>2</sub> > NMe<sub>2</sub> > NH<sup><i>i</i></sup>Pr. Removal of the alkyl group to give the free carboxylic acid (<b>4</b>) resulted in a reduction in activity from 3 to 300 nM, whereas reduction of the ester to the free alcohol (<b>15</b>) was tolerated (IC<sub>50</sub> = 40 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for Imidazole Esters, Amides, and Alcohol</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0001.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were derived from the best fit of a four point dose–response curve.</p></div></div><div></div></div><div class="NLM_p">The triazole methyl ester (<b>17</b>) showed improved subnanomolar inhibitory activity (IC<sub>50</sub> = 0.35 nM) as compared with the imidazole methyl ester lead (<b>2</b>, IC<sub>50</sub> = 3 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, a considerable reduction in activity was noted for the triazole carboxylic acid derivative (<b>18</b>, IC<sub>50</sub> > 1 μM) as compared with the imidazole carboxylic acid derivative (<b>4</b>, IC<sub>50</sub> = 300 nM), and this same trend was observed for the triazole methyl amide derivative (<b>19</b>, IC<sub>50</sub> = 350 nM) as compared with imidazole product (<b>11</b>, IC<sub>50</sub> = 12 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Triazole Compounds as Compared with Imidazole Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0002.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">CYP26 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">CYP26 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char="."><b>2</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">>1 μM</td><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">350</td><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values were derived from the best fit of a 4 point dose–response curve. Liarozole, IC<sub>50</sub> = 540 nM; R116010, IC<sub>50</sub> = 10 nM.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Enhancement of RA Effects</h3><div class="NLM_p">The induction of CYP26A1 mRNA was used to determine the ability of the compounds to enhance the biological effects of ATRA in retinoid-responsive SH-SY5Y neuroblastoma cells. Compounds with a microsomal CYP26 inhibitory IC<sub>50</sub> ≤ 50 nM were selected, and CYP26A1 mRNA was not induced by treatment of SH-SY5Y cells with these inhibitors alone at a concentration of 1 μM. Coincubation of liarozole with 0.1 μM ATRA resulted in a 2.3-fold induction in CYP26A1 mRNA as compared with 0.1 μM ATRA alone, whereas coincubation with R116010 resulted in a 4.7-fold induction of CYP26A1 mRNA, which was comparable to the induction in response to a 10-fold higher concentration of ATRA (1 μM) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Coincubation of 0.1 μM ATRA in combination with 1 μM compounds <b>2</b>, <b>5</b>, <b>10</b>, <b>11</b>, <b>15</b>, and <b>17</b> for 72 h also substantially increased expression of CYP26A1 as compared with 0.1 μM ATRA alone. Under these conditions, the two compounds with the greatest CYP26 inhibitory activity, the ethyl ester product <b>5</b> and the triazole methyl ester <b>17</b>, enhanced the expression of CYP26A1 mRNA by 5.8- and 5.2-fold, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Conversely, the two compounds with the lowest CYP26 inhibitory activity, the reduced ester <b>15</b> and the amide <b>10</b>, enhanced CYP26A1 mRNA by 3.7- and 4.1-fold, respectively, and were the least active (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Real-time PCR analysis of CYP26A1 mRNA expression after treatment with ATRA in combination with liarozole (Liar.), R116010 (R116), <b>2</b>, <b>5</b>, <b>10</b>, <b>11</b>, <b>15</b>, and <b>17</b>. SH-SY5Y cells were treated with ATRA alone (0.01–1 μM) or with ATRA (0.1 μM) in combination with inhibitor (1 μM) for 72 h. Total RNA was isolated, reverse transcribed, and subjected to real-time PCR using TaqMan probes for CYP26A1 and β-actin. Values were normalized for β-actin levels and expressed as a fold increase relative to CYP26A1 expression in SH-SY5Y cells treated with 0.01 μM ATRA. Data are mean values ± SDs (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Selectivity and Microsomal Stability</h3><div class="NLM_p">The imidazole ethyl ester (<b>5</b>), imidazole methylamide (<b>11</b>), imidazole dimethylamide (<b>13</b>), and triazole methyl ester (<b>17</b>) derivatives were evaluated for their inhibitory activity against a panel of P450 isoforms expressed in human liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in comparison with the lead imidazole methyl ester (<b>2</b>). The imidazole ethyl ester (<b>5</b>) had a CYP selectivity profile almost identical with the methyl ester lead (<b>2</b>). The amides <b>11</b> and <b>13</b> were highly active against CYP3A4 at concentrations of 0.4 μM, which would discount these compounds for further evaluation. However, at this concentration, the triazole methyl ester (<b>17</b>) was inactive against the CYP panel (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Percent Inhibition Data against CYP Panel at 0.4 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0004.gif" alt="" id="_i12" /></img><div></div></div><div class="NLM_p">To determine the selectivity of the triazole methyl ester (<b>17</b>) in comparison with R116010 and the lead imidazole methyl ester (<b>2</b>), IC<sub>50</sub> assays against CYP isoforms expressed in human liver microsomes were performed. Micromolar concentrations of compounds <b>2</b> or <b>17</b> or R116010 were needed to inhibit CYPs 1A2, 2C9, and 2C19.</div><div class="NLM_p">Furthermore, compound <b>17</b> was ≥6000-fold more potent against CYP26 as compared to CYPs 1A2, 2C9, 2C19, and 2D6, with compound <b>2</b> and R116010 ≥ 200- and ≥400-fold more potent, respectively. However, although all three compounds inhibited CYP3A4 with submicromolar activity, an improvement was observed with the triazole methyl ester (<b>17</b>) showing reduced potency against CYP3A4 (IC<sub>50</sub> = 0.33 μM) as compared with imidazole (<b>2</b>), which was comparable with R116010 (CYP3A4 IC<sub>50</sub> = 0.35 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>17</b> exhibited a low clearance rate (Cyprotex: <i>t</i><sub>1/2</sub> = 3 h and 44 min) in human liver microsomes comparable with the imidazole lead <b>2</b> (Cyprotex: <i>t</i><sub>1/2</sub> = 5 h and 1 min), indicating minimal phase I metabolism and good stability.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CYP IC<sub>50</sub> (μM) Profile of Triazole <b>17</b> as Compared with Lead <b>2</b> and R116010</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">26</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">21.4</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.0003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R116010</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling</h3><div class="NLM_p">A series of molecular docking simulations were performed on this series of compounds with ligands docked within the active site of the CYP26A1 homology model,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> following the methodology reported previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Results obtained for <b>17</b> showed a putative binding mode very similar to the one observed previously with the corresponding imidazole analogue <b>2</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In particular, the binding was dominated by a series of hydrophobic interactions: The naphthyl group lay in a channel formed, among others, by Phe222, Phe84, and Phe374, while the ester moiety was in contact with Phe299 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The naphthylphenylamine moiety is not common in drugs; however, in these inhibitors, it fulfills the role of binding the molecule in the hydrophobic tunnel of the enzyme active site and allows correct orientation of the imidazole for optimal interaction with the heme.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Putative binding mode for <b>17</b>. The Fe atom of the heme is shown as a green sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Evaluation of CYP26 inhibitory activity revealed that in the imidazole ester series, <b>2</b> and <b>5</b>–<b>9</b>, a small alkyl group was optimal with the methyl (<b>2</b>) and ethyl (<b>5</b>) esters displaying potent inhibitory activity (<b>2</b>, IC<sub>50</sub> = 3 nM; <b>5</b>, IC<sub>50</sub> = 0.35 nM) as compared with the longer and branched chain esters and bulky aromatic ester groups (<b>6</b>–<b>9</b>, IC<sub>50</sub> range = 140–400 nM). A similar pattern was observed in the amide imidazole series with the methyl amide −CONHMe (<b>11</b>) showing optimal activity (IC<sub>50</sub> = 12 nM) as compared with the dimethyl amide (<b>13</b>) and branched isopropyl amide (<b>12</b>). These data would suggest that one H-bond donor and a small alkyl group are preferred for activity in the amide series. Although the esters (<b>6</b>–<b>9</b>) and amides (<b>10</b>, <b>12</b>, and <b>13</b>) were less active than the lead compound (<b>2</b>), they were more active than liarozole (IC<sub>50</sub> = 540 nM). The 2,2-dimethyl-3-propanol derivative (<b>15</b>) also showed good inhibitory activity (IC<sub>50</sub> = 40 nM), suggesting that a carbonyl group is not essential for activity.</div><div class="NLM_p">The triazole equivalents of the most potent compounds in the imidazole series, the methyl ester (<b>2</b>) and methyl amide (<b>11</b>), were prepared for evaluation. The triazole methyl ester (<b>17</b>) was more potent with an IC<sub>50</sub> of 0.35 nM, while the triazole methyl amide (<b>19</b>) showed a reduction in activity with an IC<sub>50</sub> of 350 nM as compared with the corresponding imidazole derivatives. The triazole carboxylic acid derivative (<b>18</b>) showed a loss in activity (IC<sub>50</sub> > 1 μM) as compared with the imidazole carboxylic acid (<b>4</b>, IC<sub>50</sub> = 350 nM); this loss in activity may be related to reduced uptake; however, the metabolic stability of the ester, assessed previously,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> would suggest that the ester is the active inhibitor rather than acting as a prodrug for the carboxylic acid.</div><div class="NLM_p">Compounds with biochemical CYP26 inhibitory IC<sub>50</sub> values ≤50 nM also enhanced the biological activity of exogenous ATRA, as evidenced by a 3.7–5.8-fold increase in CYP26A1 induction as compared to ATRA alone. All compounds demonstrated an activity comparable with or better than R116010, and the induction correlated well with CYP26 inhibition data. Direct comparison of CYP selectivity profiles for triazole <b>17</b> and R116010 revealed an almost identical CYP selectivity profile; however, the greater CYP26 inhibitory activity of <b>17</b> as compared with R116010 resulted in compound <b>17</b> being ≥6000-fold more potent against CYP26 as compared with CYPs 1A2, 2C9, 2C19, and 2D6, with R116010 ≥ 400-fold more potent, respectively. Importantly, the triazole (<b>17</b>) displayed improved CYP3A4 selectivity (1100-fold more selective for CYP26) as compared with the imidazole (<b>2</b>) (<33-fold more selective for CYP26).</div><div class="NLM_p">The studies have allowed evaluation of SAR with key functional groups and optimal interactions noted (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), with the promising biological activity profile of the triazole ester <b>17</b>, suggesting that it is an appropriate candidate for further evaluation and development for use in the treatment of dermatological diseases.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Optimal SAR for the 2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl) propyl azole derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedures</h3><div class="NLM_p">[11,12-<sup>3</sup>H]-All <i>trans</i>-retinoic acid (37 MBq/mL) and Ultima Flo M scintillation fluid were purchased from Perkin-Elmer (United Kingdom). Acetic acid and ammonium acetate were obtained from Fisher Scientific (United Kingdom). All solvents used for chromatography were high-performance liquid chromatography (HPLC) grade from Fisher Scientific.</div><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with a Bruker Avance DPX500 spectrometer operating at 500 and 125 MHz, with Me<sub>4</sub>Si as an internal standard. Mass spectra were determined by the EPSRC mass spectrometry center (Swansea, United Kingdom). Microanalyses were determined by Medac Ltd. (Surrey, United Kingdom). CYP26 selectivity assays were performed by Cyprotex (Cheshire, United Kingdom). Flash column chromatography was performed with silica gel 60 (230–400 mesh) (Merck), and thin-layer chromatography (TLC) was carried out on precoated silica plates (kiesel gel 60 F<sub>254</sub>, BDH). Compounds were visualized by illumination under UV light (254 nm). Melting points were determined on an electrothermal instrument and are uncorrected. All solvents were dried prior to use as described by the handbook Purification of Laboratory Chemicals<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and stored over 4 Å molecular sieves, under nitrogen. All compounds were more than 95% pure.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell Culture and Retinoid Treatment</h3><div class="NLM_p last">SH-SY5Y or MCF-7 cells were cultured at 37 °C in RPMI 1640 medium containing fetal calf serum (10%) and <span class="smallcaps smallerCapital">l</span>-glutamine (2 mM) in a humidified atmosphere of 5% CO<sub>2</sub> in air. ATRA was dissolved in dimethyl sulfoxide and added to the culture medium as described by Armstrong et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Liarozole, R116010, and imidazole/triazole derivatives were dissolved in ethanol and diluted in cell culture medium. The final concentration of ethanol in all experiments never exceeded 0.8%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Microsomal CYP26 Inhibition Assay</h3><div class="NLM_p last">MCF-7 cells were pretreated for 24 h with 1 μm ATRA to induce CYP26 expression. Microsomes were prepared as described by Han and Choi.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Briefly, cells were homogenized in buffer A [10 mM Tris, pH 7.4, 1 mM EDTA, 0.5 M sucrose, and Complete Protease Inhibitor Cocktail (Roche, United Kingdom)] using a Dounce homogenizer, diluted with an equal volume of Tris/EDTA, and the diluted homogenate laid over a volume of buffer A equal to the original volume. Microsomes were then isolated by differential centrifugation (9000<i>g</i>, 10 min, 4 °C; 100000<i>g</i>, 60 min, 4 °C). The microsomal pellet was suspended in buffer B (10 mM Tris, pH 7.4, 1 mM EDTA, 0.25 M sucrose, and Complete Protease Inhibitor Cocktail) and stored at −70 °C. Cytochrome <i>c</i> reductase activity was calculated at 5–15 U cyt <i>c</i>/μg protein, using the cytochrome <i>c</i> reductase (NADPH) kit (Sigma) according to the manufacturer's instructions. For ATRA metabolism, 50 μg of microsomal protein was incubated in assay buffer (50 mM Tris, pH 7.4, 150 mM KCl, 10 mM MgCl<sub>2</sub>, 0.02% w/v BSA, 2 mM NADPH, 10 nM ATRA, and 0.1 μCi <sup>3</sup>H-ATRA) in amber eppendorfs in the absence or presence of CYP26 inhibitor (1–1000 nM) in a final volume of 200 μL for 1 h at 37 °C with shaking. The reaction was quenched with acetonitrile, mixed, and then centrifuged (18000<i>g</i>, 5 min, 4 °C). Resolution of retinoids was performed with a Luna C18(2) column (3 μm, 50 mm × 2 mm) using a Waters 2690 Separations Module and subsequent Radiomatic Series 500TR Flow Scintillation Analyzer (Packard Biosciences), with Empower 2 Chromatography Data Software and Flow-ONE software, respectively, for data acquisition. <sup>3</sup>H-ATRA and <sup>3</sup>H metabolites were separated by gradient reversed-phase chromatography, using mobile phase A [50% acetonitrile, 50% (0.2%) acetic acid, w/w] and mobile phase B (acetonitrile, 0.1% acetic acid, w/w). A flow rate of 0.3 mL/min was used with linear gradients employed between the specified times as follows: 0, 100% A; 5 min, 100% A; 5.5 min, 40% A, 60% B; 12 min, 40% A, 60% B; 12.5 min, 20% A, 80% B; 17.5 min, 20% A, 80% B; 18 min, 100% A; 25 min, 100% A. The scintillant flow rate was 1 mL/min. CYP26 inhibition was calculated as the percentage <sup>3</sup>H ATRA metabolite peak area formation (activity <sup>3</sup>H metabolite(s)/total activity) as compared to metabolite formation in the absence of inhibitor. IC<sub>50</sub> values were calculated by nonlinear regression analysis in SigmaPlot (Systat Software Inc., United States) using an inhibition curve constructed from a minimum of four data points. Compound <b>2</b> was used as a standard in every assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Real-Time Polymerase Chain Reaction (PCR) for CYP26A1 Expression</h3><div class="NLM_p last">RNA was isolated using an RNeasy Kit (Qiagen, Crawley, United Kingdom), reverse-transcribed and real-time PCR performed on 20 ng of cDNA using TaqMan Gene Expression products for human CYP26A1 in combination with the TaqMan Universal PCR master mix (Applied Biosystems, Warrington, United Kingdom) on a GeneAmp 5700 Sequence Detection System as described previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Method—Synthesis of the Esters (<b>5</b>–<b>9</b>)</h4><div class="NLM_p last">Methyl 3-(1<i>H</i>-imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>2</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (2.0 mmol) in EtOH (20 mL) was saponified with KOH (4.0 mmol) under reflux for 72 h. The solvent was removed under reduced pressure, then H<sub>2</sub>O (100 mL) was added, and the unreacted starting materials were extracted with diethyl ether (3 × 50 mL). The H<sub>2</sub>O layer was reduced in vacuo to give the potassium salt (<b>3</b>), which was dissolved in anhydrous DMF. Alkylbromide (2.4 mmol) was added, and the mixture was heated at 80 °C for 2 h. H<sub>2</sub>O (70 mL) was then added, and the aqueous layer was extracted with EtOAc (3 × 50 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and reduced in vacuo. The product was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 100:0 v/v increasing to 97:3 v/v).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared from reaction of (<b>2</b>) and ethylbromide in 71% yield as a white solid; mp 156–158 °C. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.62). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.21 (t, <i>J</i> = 7.0 Hz, 3H, CH<sub>2</sub><u class="uu">C</u>H<sub>3</sub>), 1.37 (s, 6H, H-3, H-4), 4.13 (q, <i>J</i> = 7.0 Hz, 1H, <u class="uu">C</u>H<sub>2</sub>CH<sub>3</sub>), 5.58 (s, 1H, H-5), 6.11 (s, 1H, NH), 7.08 (m, 3H, Ar), 7.19 (m, 2H, Ar), 7.25 (m, 2H, Ar), 7.31 (s, 1H, imid), 7.35 (m, 1H, Ar), 7.41 (m, 1H, Ar), 7.49 (d, <i>J</i> = 8.2 Hz, 1H, Ar), 7.77 (m, 1H, Ar), 7.85 (m, 2H, Ar). EI-HRMS (M + H)<sup>+</sup> found, 414.2179; calcd for C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 414.2181.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Butyl 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared from reaction of (<b>2</b>) and butylbromide in 67% yield as a yellow oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.96 (t, <i>J</i> = 6.9 Hz, 3H, butyl), 1.23 (m, 8H, CH<sub>2</sub>-butyl, H-3, H-4), 1.48 (m, 2H, butyl), 4.12 (t, <i>J</i> = 6.6 Hz, 2H, butyl), 5.08 (s, 1H, H-7), 5.93 (s, 1H, NH), 7.15 (d, <i>J</i> = 8.0 Hz, 2H, Ar), 7.22 (m, 2H, Ar), 7.41 (m, 3H, Ar), 7.50 (s, 1H, imid), 7.52 (s, 1H, imid), 7.74 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.82 (m, 3H, Ar). EI-HRMS (M + H)<sup>+</sup> found, 442.2483; calcd for C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub>, 442.2489.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Pentyl 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared from reaction of (<b>2</b>) and pentylbromide in 69% yield as a yellow oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.95 (t, <i>J</i> = 6.8 Hz, 3H, pentyl), 1.25 (m, 10H, 2 × CH<sub>2</sub> pentyl, H-3, H-4), 1.52 (m, 2H, pentyl), 4.08 (t, <i>J</i> = 6.5 Hz, 2H, pentyl), 5.55 (s, 1H, H-5), 6.01 (s, 1H, NH), 7.19 (m, 4H, Ar), 7.33 (m, 3H, Ar), 7.42 (m, 1H, Ar), 7.48 (m, 2H, Ar), 7.74 (m, 2H, Ar), 7.82 (m, 2H, Ar). EI-HRMS (M + H)<sup>+</sup> found, 456.2637; calcd for C<sub>29</sub>H<sub>33</sub>N<sub>3</sub>O<sub>2</sub>, 456.2632.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Isopropyl 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared from reaction of (<b>2</b>) and isopropylbromide in 68% yield as a white solid; mp 166–168 °C. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.11 (d, <i>J</i> = 6.8 Hz, 6H, <i><sup>i</sup></i>Pr), 1.29 (s, 6H, H-3, H-4), 4.93 (sep, <i>J</i> = 6.8 Hz, 1H, <sup><i>i</i></sup>Pr), 5.54 (s, 1H, H-5), 6.13 (s, 1H, NH), 7.07 (d, <i>J</i> = 8.1 Hz, 2H, Ar), 7.19 (m, 2H, Ar), 7.27 (m, 2H, Ar), 7.31 (s, 1H, imid), 7.39 (m, 1H, Ar), 7.50 (m, 2H, Ar), 7.68 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.76 (d, <i>J</i> = 8.3 Hz, 2H, Ar). EI-HRMS (M)<sup>+</sup> found, 428.2337; calcd for C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>, 428.2338.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Benzyl 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared from reaction of (<b>2</b>) and benzylbromide in 57% yield as a yellow oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.25 (s, 6H, H-3, H-4), 5.06 (s, 2H, benzyl), 5.55 (s, 1H, H-5), 5.94 (s, 1H, NH), 7.08 (d, <i>J</i> = 8.0 Hz, 2H, Ar), 7.15 (d, <i>J</i> = 7.8 Hz, 2H, Ar), 7.21 (m, 4H, Ar), 7.36 (m, 5H, Ar), 7.47 (m, 3H, Ar), 7.66 (d, <i>J</i> = 8.1 Hz, 1H, Ar), 7.71 (m, 2H, Ar). EI-HRMS (M + H)<sup>+</sup> found, 476.2323; calcd for C<sub>31</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>, 476.2319.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl] Propanoic Acid (<b>4</b>)</h4><div class="NLM_p last">Methyl 3-(1<i>H</i>-imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate (<b>2</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (2.0 mmol) in EtOH (20 mL) was saponified with KOH (4.0 mmol) under reflux for 72 h. The solvent was removed under reduced pressure, H<sub>2</sub>O (100 mL) was added, and the unreacted starting materials were extracted with ether (3 × 50 mL). The H<sub>2</sub>O layer was acidified with 1 N aqueous HCl until pH 3 and extracted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The organic layer was dried (MgSO<sub>4</sub>), and the solvent was removed under reduced pressure to give the product in 64% yield as a brown solid; mp 148–150 °C. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.21). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.25 (s, 3H, H-3), 1.33 (s, 3H, H-4), 5.67 (s, 1H, H-NH), 7.07 (d, <i>J</i> = 8.0 Hz, 2H, Ar), 7.11 (s, 1H, H-5), 7.17 (s, 1H, Ar), 7.25 (m, 2H, Ar), 7.32 (m, 3H, Ar), 7.47 (s, 1H, imid), 7.50 (s, 1H, imid), 7.71 (d, <i>J</i> = 8.2 Hz, 1H, Ar), 7.83 (s, 1H, imid), 7.77 (m, 2H, Ar), 8.23 (s, 1H, CO<sub>2</sub>H). EI-HRMS (M + H)<sup>+</sup> found, 386.1865; calcd for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 386.1863.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> General Method—Synthesis of the Amides</h4><div class="NLM_p last">EDC (0.18 mmol), carboxylic acid (<b>4</b> or <b>18</b>) (0.18 mmol), and HOBt (0.18 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were stirred at room temperature under N<sub>2</sub> for 0.5 h. Amine (0.56 mmol) was added, and the reaction mixture was stirred overnight. EtOAc (70 mL) was added, and the organic layer was washed with 1 M aqueous HCl (30 mL), saturated aqueous NaHCO<sub>3</sub> (30 mL), brine (30 mL), and H<sub>2</sub>O (30 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and reduced in vacuo. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 100:0 v/v increasing to 98:2 v/v).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanamide (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared from reaction of (<b>4</b>) and methanolic NH<sub>3</sub> in 71% yield as a brown oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.47). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.27 (s, 3H, H-3), 1.29 (s, 3H, H-4), 5.53 (s, 1H, H-5), 5.59 (s, 2H, NH<sub>2</sub>), 5.89 (s, 1H, NH), 7.05 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.17 (s, 1H, imid), 7.22 (m, 4H, Ar), 7.29 (m, 1H, Ar), 7.35 (m, 1H, Ar), 7.46 (s, 1H, imid), 7.63 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.73 (d, <i>J</i> = 8.1 Hz, 2H, Ar), 7.81 (s, 1H, imid). EI-HRMS (M + H)<sup>+</sup> found, 385.2026; calcd for C<sub>24</sub>H<sub>24</sub>N<sub>4</sub>O, 385.2028.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(1<i>H</i>-Imidazol-1-yl)-<i>N</i>,2,2-trimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanamide (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared from reaction of (<b>4</b>) and 33% methylamine in absolute EtOH in 75% yield as a brown solid; mp 120–124 °C. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.50). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.26 (s, 3H, H-3), 1.29 (s, 3H, H-4), 2.75 (d, <i>J</i> = 2.5 Hz, 3H, NHC<u class="uu">H</u><sub>3</sub>), 5.62 (s, 1H, H-5), 5.77 (d, <i>J</i> = 2.5 Hz, 1H, N<u class="uu">H</u>CH<sub>3</sub>), 6.11 (s, 1H, NH), 7.04 (s, 1H, imid), 7.09 (d, <i>J</i> = 8.2 Hz, 1H, Ar), 7.15 (s, 1H, imid), 7.22 (m, 4H, Ar), 7.30 (m, 1H, Ar), 7.39 (m, 1H, Ar), 7.45 (d, <i>J</i> = 2.6 Hz, 1H, Ar), 7.65 (m, 2H, Ar), 7.76 (d, <i>J</i> = 8.1 Hz, 2H, Ar). Anal. C, H, N.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(1<i>H</i>-Imidazol-1-yl)-<i>N</i>-isopropyl-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanamide (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared from reaction of (<b>4</b>) and isopropylamine in 64% yield as a pale yellow oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.56). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.08 (d, <i>J</i> = 6.6 Hz, 6H, NH<sup><i>i</i></sup>Pr), 1.25 (s, 3H, H-3), 1.29 (s, 3H, H-4), 4.13 (sep, <i>J</i> = 6.6 Hz, 1H, NH<i><sup>i</sup></i>Pr), 5.41 (d, <i>J</i> = 6.6 Hz, 1H, N<u class="uu">H</u><sup><i>i</i></sup>Pr), 5.63 (s, 1H, NH), 6.16 (s, 1H, H-5), 7.08 (m, 3H, Ar), 7.23 (m, 4H, Ar), 7.30 (m, 1H, Ar), 7.44 (m, 2H, Ar), 7.65 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.74 (d, <i>J</i> = 8.3 Hz, 2H, Ar). EI-HRMS (M + H)<sup>+</sup> found, 427.2492; calcd for C<sub>27</sub>H<sub>30</sub>N<sub>4</sub>O, 427.2492.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(1<i>H</i>-Imidazol-1-yl)-<i>N</i>,<i>N</i>,2,2-tetramethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanamide (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared from reaction of (<b>4</b>) and dimethylamine (2 M in THF) in 61% yield as a brown oil. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.59). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.37 (s, 3H, H-3), 1.41 (s, 3H, H-4), 2.95 (s, 6H, N(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>), 5.80 (s, 1H, H-5), 6.23 (s, 1H, NH), 7.08 (m, 4H, Ar), 7.25 (m, 3H, Ar), 7.36 (m, 1H, Ar), 7.41 (m, 1H, Ar), 7.45 (d, <i>J</i> = 2.6 Hz, 1H, Ar), 7.66 (d, <i>J</i> = 7.8 Hz, 1H, Ar), 7.72 (m, 3H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 24.34 (CH<sub>3</sub>, C-3), 25.16 (CH<sub>3</sub>, C-4), 38.75 (2 × CH<sub>3</sub>, N(<u class="uu">C</u>H<sub>3</sub>)<sub>2</sub>), 47.93 (C, C-2), 68.69 (CH, C-5), 112.91, 116.91, 120.50, 123.86, 123.92, 126.52, 127.65 (10 × CH), 128.11 (C), 129.24 (CH, imid), 129.51 (C), 129.93 (CH, imid), 129.99 (2 × CH), 134.49, 139.86, 143.67, 175.05 (4 × C). EI-HRMS (M + H)<sup>+</sup> found, 413.2335; calcd for C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O, 413.2336.</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>,2,2-Trimethyl-3-[4-(naphthalen-2-ylamino)phenyl]-3-(1<i>H</i>-1,2,4-triazol-1-yl)propanamide (<b>19</b>)</h4><div class="NLM_p last">This compound was prepared from (<b>18</b>) and 33% methylamine in absolute EtOH in 63% yield as a pale yellow oil. TLC (98:2 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.51). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.33 (s, 6H, H-3, H-4), 2.71 (d, <i>J</i> = 2.7 Hz, 3H, NHC<u class="uu">H</u><sub>3</sub>), 5.78 (d, <i>J</i> = 2.8 Hz, 1H, N<u class="uu">H</u>CH<sub>3</sub>), 5.87 (s, 1H, NH), 7.08 (d, <i>J</i> = 7.5 Hz, 2H, Ar), 7.16–7.19 (m, 1H, Ar), 7.26–7.29 (m, 1H, Ar), 7.37–7.40 (m, 1H, Ar), 7.45–7.50 (m, 3H, Ar), 7.65 (d, <i>J</i> = 7.6 Hz, 1H, Ar), 7.74 (d, <i>J</i> = 7.5 Hz, 2H, Ar), 7.99 (s, 1H, triaz), 8.19 (s, 1H, triaz). EI-HRMS (M)<sup>+</sup> found, 400.2133; calcd for C<sub>24</sub>H<sub>25</sub>N<sub>5</sub>O, 400.2132.</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(1<i>H</i>-Imidazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propan-1-ol (<b>15</b>)</h4><div class="NLM_p last">A solution of (<b>14</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (0.23 mmol) in dry THF (10 mL) under N<sub>2</sub> was cooled to 0 °C. LiAlH<sub>4</sub> (1 M in THF, 1.2 mmol) was added dropwise, and the reaction mixture was stirred at 0 °C for 1 h and then at room temperature overnight. The reaction was quenched by the addition of EtOAc (70 mL). The organic layer was washed with H<sub>2</sub>O (50 mL), dried (MgSO<sub>4</sub>), and reduced in vacuo. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 100:0 v/v increasing to 97:3 v/v) to give the product as a light brown oil in 79% yield. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.60). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.07 (s, 3H, H-3), 1.71 (s, 3H, H-4), 2.48 (s, 1H, OH), 3.26 (d, <i>J</i> = 8.0 Hz, 1H, C<u class="uu">H</u><sub>2</sub>OH), 3.30 (d, <i>J</i> = 8.0 Hz, 1H, C<u class="uu">H</u><sub>2</sub>OH), 3.91 (s, 3H, OCH<sub>3</sub>), 5.38 (s, 1H, H-5), 5.91 (s, 1H, H-NH), 7.03 (d, <i>J</i> = 7.8 Hz, 2H, Ar), 7.11 (m, 3H, Ar), 7.22 (m, 2H, Ar), 7.33 (d, <i>J</i> = 7.7 Hz, 2H, Ar), 7.42 (d, <i>J</i> = 2.8 Hz, 1H, Ar), 7.57 (d, <i>J</i> = 8.1 Hz, 1H, Ar), 7.69 (d, <i>J</i> = 8.2 Hz, 1H, Ar), 7.73 (s, 1H, Ar). EI-HRMS (M)<sup>+</sup> found, 402.2176; calcd for C<sub>25</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 402.2176.</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 2,2-Dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]-3-(1<i>H</i>-1,2,4-triazol-1-yl)propanoate (<b>17</b>)</h4><div class="NLM_p last">To a solution of alcohol (<b>16</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (1.5 mmol) in anhydrous CH<sub>3</sub>CN (20 mL) were added triazole (6 mmol) and CDT (3 mmol). The mixture was then heated under reflux for 48 h. The reaction mixture was allowed to cool and then extracted with EtOAc (150 mL) and H<sub>2</sub>O (3 × 100 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and reduced in vacuo. The product was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 100:0 v/v increasing to 98:2 v/v) to give the product as a brown oil. Yield, 63%. TLC (99:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.57). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.37 (s, 3H, H-3), 1.40 (s, 3H, H-4), 3.67 (s, 3H, OCH<sub>3</sub>), 6.16 (s, 1H, CH), 6.25 (s, 1H, NH), 7.10 (d, <i>J</i> = 8.7 Hz, 2H, Ar), 7.25 (dd, <i>J</i> = 2.3, 8.7 Hz, 1H, Ar), 7.34 (ddd, <i>J</i> = 1.1, 7.0, 8.1 Hz, 1H, Ar), 7.40–7.45 (m, 3H, Ar), 7.49 (d, <i>J</i> = 2.1 Hz, 1H, Ar), 7.68 (d, <i>J</i> = 8.1 Hz, 1H, Ar), 7.76 (d, <i>J</i> = 8.8 Hz, 2H, Ar), 8.00 (s, 1H, H-triaz), 8.14 (s, 1H, triaz). EI-HRMS (M + Na)<sup>+</sup> found, 423.1786; calcd for C<sub>24</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>Na, 423.1789.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2,2-Dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)-3-(1<i>H</i>-1,2,4-triazol-1-yl)propanoic Acid (<b>18</b>)</h4><div class="NLM_p last">To a solution of (<b>17</b>) (2 mmol) in THF (5 mL) was added an aqueous solution of LiOH (4 mmol in 5 mL H<sub>2</sub>O), and the mixture was homogenized with methanol and heated under gentle reflux for 2 h. The solvent was removed under reduced pressure, H<sub>2</sub>O (100 mL) was added, and the unreacted starting materials were extracted with ether (3 × 50 mL). The H<sub>2</sub>O layer was acidified with 1 N HCl until pH 3 and extracted with ether (100 mL). The organic layer was dried (MgSO<sub>4</sub>), and the solvent was removed under reduced pressure to give the product as a brown oil in 77% yield. TLC (97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, <i>R<sub>f</sub></i> = 0.36). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.23 (s, 3H, H-3), 1.31 (s, 3H, H-4), 5.73 (s, 1H, H-5), 6.27 (s, 1H, NH), 7.13 (d, <i>J</i> = 7.3 Hz, 2H, Ar), 7.32–7.42 (m, 6H, Ar), 7.69 (d, <i>J</i> = 7.4 Hz, 1H, Ar), 7.76 (d, <i>J</i> = 7.5 Hz, 2H, Ar), 8.01 (s, 1H, triaz), 8.22 (s, 1H, COOH), 8.31 (s, 1H, triaz). EI-HRMS (M + H)<sup>+</sup> found, 387.1816; calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>, 387.1818.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Molecular Modeling</h3><div class="NLM_p last">All molecular modeling studies were performed on a MacPro dual 2.66 GHz Xeon running Ubuntu 9. Ligand structures were built in MOE<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> minimized using the MMFF94x forcefield until a rmsd gradient of 0.05 kcal mol<sup>–1</sup> Å<sup>–1</sup> was reached. Docking simulations were performed using PLANTS<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (aco_ants 20; aco_evap 0.15; aco_sigma 5.0), with ligands docked within the active site of the CYP26A1 homology model,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the results were visualized in MOE. Molecular dynamics simulations were performed with GROMACS<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> and the Gromos96 force field in a NPT environment. Individual ligand/protein complexes obtained from the docking results were soaked in a triclinic water box and minimized using a steepest descent algorithm to remove unfavorable van der Waals contacts. The system was then equilibrated via a 100 ps MD simulation at 300 K with restrained ligand/protein complex atoms. Finally, a 5 ns simulation was performed at 300 K with a time step of 2 fs and hydrogen atoms constrained with a LINCS algorithm. Visualization of the dynamics trajectories was performed with the VMD software package, version 1.8.3.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm200695m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Numbering of compounds for <sup>1</sup>H and <sup>13</sup>C NMR characterization and <sup>13</sup>C NMR spectroscopic data for compounds <b>4</b>– <b>12</b>, <b>15</b>, and <b>17</b>–<b>19</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200695m/suppl_file/jm200695m_si_001.pdf">jm200695m_si_001.pdf (140.31 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200695m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane L. Armstrong</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, and §Institute of Cellular Medicine, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#701a5e1c5e11021d0304021f1e17301e1507131103041c155e11135e051b5023191d1f1e033330331102141916165e11135e051b"><span class="__cf_email__" data-cfemail="86eca8eaa8e7f4ebf5f2f4e9e8e1c6e8e3f1e5e7f5f2eae3a8e7e5a8f3ed">[email protected]</span> <span class="__cf_email__" data-cfemail="82d1ebefedecf1c1c2c1e3f0e6ebe4e4ace3e1acf7e9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Simons</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f298dc9edc93809f8186809d9c95b29c9785919381869e97dc9391dc8799d2a19b9f9d9c81b1b2b19380969b9494dc9391dc8799"><span class="__cf_email__" data-cfemail="52387c3e7c33203f2126203d3c35123c3725313321263e377c33317c2739">[email protected]</span> <span class="__cf_email__" data-cfemail="57043e3a3839241417143625333e313179363479223c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed S. Gomaa</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline E. Bridgens</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, and §Institute of Cellular Medicine, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gareth J. Veal</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, and §Institute of Cellular Medicine, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher P. F. Redfern</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, and §Institute of Cellular Medicine, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Brancale</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Division, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, United Kingdom</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Cancer Research UK for funding (M.S.G. and C.E.B., Grant ref. C7735/A9612) and the EPSRC Mass Spectrometry Centre, Swansea, United Kingdom, for mass spectroscopy data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">ATRA</td><td class="NLM_def"><p class="first last">all-<i>trans</i>-retinoic acid</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">retinoic acid</p></td></tr><tr><td class="NLM_term">RAMBAs</td><td class="NLM_def"><p class="first last">retinoic acid metabolism blocking agents</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gudas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Retinoids regulate stem cell differentiation</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1002%2Fjcp.22417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=20836077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=322-330&author=L.+J.+Gudasauthor=J.+A.+Wagner&title=Retinoids+regulate+stem+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoids regulate stem cell differentiation</span></div><div class="casAuthors">Gudas, Lorraine J.; Wagner, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-330</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Retinoids are ubiquitous signaling mols. that influence nearly every cell type, exert profound effects on development, and complement cancer chemotherapeutic regimens.  All-trans retinoic acid (RA) and other active retinoids are generated from vitamin A (retinol), but key aspects of the signaling pathways required to produce active retinoids remain unclear.  Retinoids generated by one cell type can affect nearby cells, so retinoids also function in intercellular communication.  RA induces differentiation primarily by binding to RARs, transcription factors that assoc. with RXRs and bind RAREs in the nucleus.  Binding of RA: (1) initiates changes in interactions of RAR/RXRs with co-repressor and co-activator proteins, activating transcription of primary target genes; (2) alters interactions with proteins that induce epigenetic changes; (3) induces transcription of genes encoding transcription factors and signaling proteins that further modify gene expression (e.g., FOX03A, Hoxa1, Sox9, TRAIL, UBE2D3); and (4) results in alterations in estrogen receptor α signaling.  Proteins that bind at or near RAREs include Sin3a, N-CoR1, PRAME, Trim24, NRIP1, Ajuba, Zfp423, and MN1/TEL.  Interactions among retinoids, RARs/RXRs, and these proteins explain in part the powerful effects of retinoids on stem cell differentiation.  Studies of this retinol signaling cascade enhance our ability to understand and regulate stem cell differentiation for therapeutic and scientific purposes.  In cancer chemotherapeutic regimens retinoids can promote tumor cell differentiation and/or induce proteins that sensitize tumors to drug combinations.  Mechanistic studies of retinoid signaling continue to suggest novel drug targets and will improve therapeutic strategies for cancer and other diseases, such as immune-mediated inflammatory diseases.  J. Cell. Physiol. 226: 322-330, 2011. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1IVNhZBJYLVg90H21EOLACvtfcHk0lgK5_dnnO2P7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt7vI&md5=ec15d60914270bd1ac767db3e0d4a976</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22417%26sid%3Dliteratum%253Aachs%26aulast%3DGudas%26aufirst%3DL.%2BJ.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DRetinoids%2520regulate%2520stem%2520cell%2520differentiation%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D322%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fields, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soprano, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soprano, K. J.</span><span> </span><span class="NLM_article-title">Retinoids in biological control and cancer</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=886-898&author=A.+L.+Fieldsauthor=D.+R.+Sopranoauthor=K.+J.+Soprano&title=Retinoids+in+biological+control+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DA.%2BL.%26aulast%3DSoprano%26aufirst%3DD.%2BR.%26aulast%3DSoprano%26aufirst%3DK.%2BJ.%26atitle%3DRetinoids%2520in%2520biological%2520control%2520and%2520cancer%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D886%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Orfanos, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouboulis, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond-Roesler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geilen, C. C.</span><span> </span><span class="NLM_article-title">Current use and future potential role of retinoids in dermatology</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=358-388&author=C.+E.+Orfanosauthor=C.+C.+Zouboulisauthor=B.+Almond-Roeslerauthor=C.+C.+Geilen&title=Current+use+and+future+potential+role+of+retinoids+in+dermatology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrfanos%26aufirst%3DC.%2BE.%26aulast%3DZouboulis%26aufirst%3DC.%2BC.%26aulast%3DAlmond-Roesler%26aufirst%3DB.%26aulast%3DGeilen%26aufirst%3DC.%2BC.%26atitle%3DCurrent%2520use%2520and%2520future%2520potential%2520role%2520of%2520retinoids%2520in%2520dermatology%26jtitle%3DDrugs%26date%3D1997%26volume%3D53%26spage%3D358%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fritsch, P. O.</span><span> </span><span class="NLM_article-title">Retinoids in psoriasis and disorders of keratinization</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S8</span><span class="NLM_x">–</span> <span class="NLM_lpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1992&pages=S8-S14&author=P.+O.+Fritsch&title=Retinoids+in+psoriasis+and+disorders+of+keratinization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFritsch%26aufirst%3DP.%2BO.%26atitle%3DRetinoids%2520in%2520psoriasis%2520and%2520disorders%2520of%2520keratinization%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D1992%26volume%3D27%26spage%3DS8%26epage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Thielitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautheim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollnick, H.</span><span> </span><span class="NLM_article-title">Update in retinoid therapy of acne</span> <span class="citation_source-journal">Dermatol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1529-8019.2006.00084.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17014482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD28rosV2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=272-279&author=A.+Thielitzauthor=A.+Krautheimauthor=H.+Gollnick&title=Update+in+retinoid+therapy+of+acne"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Update in retinoid therapy of acne</span></div><div class="casAuthors">Thielitz Anja; Krautheim Andrea; Gollnick Harald</div><div class="citationInfo"><span class="NLM_cas:title">Dermatologic therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">272-9</span>
        ISSN:<span class="NLM_cas:issn">1396-0296</span>.
    </div><div class="casAbstract">The pathogenesis of acne, the most common skin disease, is complex and multifactorial.  Clinical experience has demonstrated that parallel targeting of various pathogenetic factors, achieved either by mono- or combination therapy with appropriate drugs, represents the most effective approach to treating acne.  Topical retinoids have been shown to expulse mature comedones, reduce microcomedone formation, and exert immunomodulatory effects.  They have broad anti-acne activity without the risk of inducing bacterial resistance, which justifies their use as first-line treatment in most types of noninflammatory and inflammatory acne and makes them uniquely suitable as long-term medication to maintain remission after cessation of initial combination therapy.  Systemic isotretinoin as a monotherapeutic agent strongly affects all four major pathogenetic factors and has been, in the hand of experienced dermatologists, a potent and safe agent for the treatment of severe and recalcitrant acne forms for more that 20 years.  However, patient counseling, careful monitoring, and evaluation and management of adverse events are necessary.  The use of isotretinoin has experienced a drawback now that its indication has been lowered from a first-line to a second-line medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxWKerTm1WqjToTC3aBaesfW6udTcc2eaVUlIFr4qZU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rosV2nsg%253D%253D&md5=bdb1f7115ad68812e2c33dde59e16dd1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1529-8019.2006.00084.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1529-8019.2006.00084.x%26sid%3Dliteratum%253Aachs%26aulast%3DThielitz%26aufirst%3DA.%26aulast%3DKrautheim%26aufirst%3DA.%26aulast%3DGollnick%26aufirst%3DH.%26atitle%3DUpdate%2520in%2520retinoid%2520therapy%2520of%2520acne%26jtitle%3DDermatol.%2520Ther.%26date%3D2006%26volume%3D19%26spage%3D272%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brecher, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlow, S. J.</span><span> </span><span class="NLM_article-title">Oral retinoid therapy for dermatological conditions in children and adolescents</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1067%2FS0190-9622%2803%2901564-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=12894062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD3szmtVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=171-182&author=A.+R.+Brecherauthor=S.+J.+Orlow&title=Oral+retinoid+therapy+for+dermatological+conditions+in+children+and+adolescents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Oral retinoid therapy for dermatologic conditions in children and adolescents</span></div><div class="casAuthors">Brecher Alexandra R; Orlow Seth J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-82; quiz 183-6</span>
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    </div><div class="casAbstract">The efficacy of systemic retinoid therapy in a number of dermatologic diseases is well established; however, concerns about potential side effects limit their use, especially in children.  We review the efficacy and toxicity of oral retinoids in the pediatric population.  The acute mucocutaneous toxicities commonly observed are typically well tolerated, readily treatable, and reversible.  Systemic toxicities include teratogenicity and effects on the musculoskeletal, neurologic, and gastrointestinal systems.  Children, like adults, generally tolerate short-term retinoid therapy without major complications.  Concerns regarding serious systemic side effects are greater for those on high doses of oral synthetic retinoids for longer periods of time.  Close patient monitoring and patient education can minimize the occurrence of complications. (J Am Acad Dermatol 2003;49:171-82.)Learning objective At the conclusion of this learning activity, participants should be familiar with use of oral retinoids for childhood dermatologic conditions such as psoriasis, acne, and ichthyoses as well as safety and risks associated with oral retinoid use in children and adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRCD0a7bwSaCSm0e6ZOaemfW6udTcc2eaVUlIFr4qZU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szmtVKjsw%253D%253D&md5=29d080e6e2ab84272580cbf4d1963aa1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1067%2FS0190-9622%2803%2901564-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252FS0190-9622%252803%252901564-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrecher%26aufirst%3DA.%2BR.%26aulast%3DOrlow%26aufirst%3DS.%2BJ.%26atitle%3DOral%2520retinoid%2520therapy%2520for%2520dermatological%2520conditions%2520in%2520children%2520and%2520adolescents%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2003%26volume%3D49%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sanz, M. A.</span><span> </span><span class="NLM_article-title">Treatment of acute promyelocytic leukemia</span> <span class="citation_source-journal">Hematol. Am. Soc. Hematol. Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1182%2Fasheducation-2006.1.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17124054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD28nosFygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=147-155&author=M.+A.+Sanz&title=Treatment+of+acute+promyelocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of acute promyelocytic leukemia</span></div><div class="casAuthors">Sanz Miguel A</div><div class="citationInfo"><span class="NLM_cas:title">Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-55</span>
        ISSN:<span class="NLM_cas:issn">1520-4391</span>.
    </div><div class="casAbstract">Cure of acute promyelocytic leukemia (APL) is now a possibility for most patients through the use of state-of-the-art treatments, which include simultaneous administration of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy for induction and consolidation, as well as ATRA-based maintenance.  Risk-adapted strategies to modulate treatment intensity may be an effective approach to minimize therapy-related morbidity and mortality while maintaining the potential of cure.  In this context, there is no role for hematopoietic stem cell transplantation (HSCT) in front-line therapy, except for the small fraction of patients with persistent minimal residual disease at the end of consolidation.  However, HSCT plays an important role for patients in second complete remission.  In contrast, an increasing role of arsenic trioxide (ATO) is emerging.  Given the high antileukemic efficacy observed with ATO in patients relapsing after ATRA-containing regimens, this agent is currently regarded as the best treatment option in this setting.  However, until a randomized comparison between the standard therapy and ATO-based regimens in front-line therapy is available, this latter approach should only be recommended for unfit patients for whom chemotherapy is contraindicated.  In addition to reviewing current consensus and controversial issues on antileukemic strategies, this review addresses other aspects that can be crucial for the outcome of individual patients.  These aspects include supportive care, recognition and treatment of life-threatening complications, evaluation of response, and, finally, management of the disease in special conditions such as older patients, children and pregnant women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgiTy_lAvZN-98rul4nhSdfW6udTcc2ebKQA13CYnwkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nosFygug%253D%253D&md5=24a807dab9f5e7c4293fc13c7f300d53</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2006.1.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2006.1.147%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DM.%2BA.%26atitle%3DTreatment%2520of%2520acute%2520promyelocytic%2520leukemia%26jtitle%3DHematol.%2520Am.%2520Soc.%2520Hematol.%2520Educ.%2520Program%26date%3D2006%26spage%3D147%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Imaizumi, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kigasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horibe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukimoto, I.</span><span> </span><span class="NLM_article-title">Prospective study of a therapeutic regimen with all-<i>trans</i> retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2141.2010.08332.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=20735397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=89-98&author=M+Imaizumiauthor=A+Tawaauthor=R.+Hanadaauthor=M.+Tsuchidaauthor=K.+Tabuchiauthor=H.+Kigasawaauthor=R.+Kobayashiauthor=A.+Morimotoauthor=H.+Nakayamaauthor=K.+Hamamotoauthor=K.+Kudoauthor=H.+Yabeauthor=K.+Horibeauthor=S.+Tsuchiyaauthor=I.+Tsukimoto&title=Prospective+study+of+a+therapeutic+regimen+with+all-trans+retinoic+acid+and+anthracyclines+in+combination+of+cytarabine+in+children+with+acute+promyelocytic+leukaemia%3A+The+Japanese+childhood+acute+myeloid+leukaemia+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study</span></div><div class="casAuthors">Imaizumi, Masue; Tawa, Akio; Hanada, Ryoji; Tsuchida, Masahiro; Tabuchi, Ken; Kigasawa, Hisato; Kobayashi, Ryoji; Morimoto, Akira; Nakayama, Hideki; Hamamoto, Kazuko; Kudo, Kazuko; Yabe, Hiromasa; Horibe, Keizo; Tsuchiya, Shigeru; Tsukimoto, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In childhood acute promyelocytic leukemia (APL), the efficacy of therapy combining cytarabine with all-trans retinoic acid (ATRA) and anthracyclines remains unclear in terms of long-term prognosis.  Between August 1997 and March 2004, 58 children with APL (median age: 11 years) were enrolled into an acute myeloid leukemia (AML) study (AML99-M3) and followed up for a median time of 86 mo.  The regimen included ATRA and anthracyclines combined with cytarabine in both induction and consolidation.  In induction, two patients died of hemorrhage and four patients developed retinoic acid syndrome.  Of 58 patients, 56 (96.6%) achieved complete remission, two of whom relapsed in the bone marrow after 15 and 19 mo resp.  Sepsis was a major complication, with an incidence of 5.6-10.9% in the consolidation blocks, from which all but one of patients recovered.  Consequently, 7-yr overall and event-free survival rates were 93.1% and 91.4% resp., and cumulative incidence of relapse plateaued at 3.6% after 2 years.  Follow-up survey of 54 patients revealed no patients with late cardiotoxicity or secondary malignancy, except one with asymptomatic prolongation of QTc interval.  This study suggests that the combination of cytarabine with ATRA and anthracycline-based therapy may have useful implications in the perspective of long-term prognosis and late adverse effects for childhood APL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlzzOAV4lE-LVg90H21EOLACvtfcHk0lhGZUoKLjNgaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GlsL0%253D&md5=31f7d88176e001a94b183fa4bfa84776</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2010.08332.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2010.08332.x%26sid%3Dliteratum%253Aachs%26aulast%3DImaizumi%26aufirst%3DM%26aulast%3DTawa%26aufirst%3DA%26aulast%3DHanada%26aufirst%3DR.%26aulast%3DTsuchida%26aufirst%3DM.%26aulast%3DTabuchi%26aufirst%3DK.%26aulast%3DKigasawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DR.%26aulast%3DMorimoto%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DHamamoto%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DK.%26aulast%3DYabe%26aufirst%3DH.%26aulast%3DHoribe%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTsukimoto%26aufirst%3DI.%26atitle%3DProspective%2520study%2520of%2520a%2520therapeutic%2520regimen%2520with%2520all-trans%2520retinoic%2520acid%2520and%2520anthracyclines%2520in%2520combination%2520of%2520cytarabine%2520in%2520children%2520with%2520acute%2520promyelocytic%2520leukaemia%253A%2520The%2520Japanese%2520childhood%2520acute%2520myeloid%2520leukaemia%2520cooperative%2520study%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2011%26volume%3D152%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Matthay, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas-Kogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villablanca, J. G.</span><span> </span><span class="NLM_article-title">Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1200%2FJCO.2007.13.8925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=19171716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVCjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1007-1013&author=K.+K.+Matthayauthor=C.+P.+Reynoldsauthor=R.+C.+Seegerauthor=H.+Shimadaauthor=E.+S.+Adkinsauthor=D.+Haas-Koganauthor=R.+B.+Gerbingauthor=W.+B.+Londonauthor=J.+G.+Villablanca&title=Long-term+results+for+children+with+high-risk+neuroblastoma+treated+on+a+randomized+trial+of+myeloablative+therapy+followed+by+13-cis-retinoic+acid%3A+A+children%27s+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study</span></div><div class="casAuthors">Matthay, Katherine K.; Reynolds, C. Patrick; Seeger, Robert C.; Shimada, Hiroyuki; Adkins, E. Stanton; Haas-Kogan, Daphne; Gerbing, Robert B.; London, Wendy B.; Villablanca, Judith G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: We assessed the long-term outcome of patients enrolled on CCG-3891, a high-risk neuroblastoma study in which patients were randomly assigned to undergo autologous purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent treatment with 13-cis-retinoic acid (cis-RA).  Patients and Methods: Patients received the same induction chemotherapy, with random assignment (N = 379) to consolidation with myeloablative chemotherapy, total-body irradn., and ABMT vs. three cycles of intensive chemotherapy.  Patients who completed consolidation without disease progression were randomly assigned to receive no further therapy or cis-RA for 6 mo.  Results: The event-free survival (EFS) for patients randomly assigned to ABMT was significantly higher than those randomly assigned to chemotherapy; the 5-yr EFS (mean ± SE) was 30% ± 4% vs. 19% ± 3%, resp. (P = .04).  The 5-yr EFS (42% ± 5% v 31% ± 5%) from the time of second random assignment was higher for cis-RA than for no further therapy, though it was not significant.  Overall survival (OS) was significantly higher for each random assignment by a test of the log(-log(.)) transformation of the survival ests. at 5 years (P < .01).  The 5-yr OS from the second random assignment of patients who underwent both random assignments and who were assigned to ABMT/cis-RA was 59% ± 8%; for ABMT/no cis-RA, it was 41% ± 7%; for continuing chemotherapy/cis-RA, it was 38% ± 7%; and for chemotherapy/no cis-RA, it was 36% ± 7%.  Conclusion: Myeloablative therapy and autologous hematopoietic cell rescue result in significantly better 5-yr EFS and OS than nonmyeloablative chemotherapy; cis-RA given after consolidation independently results in significantly improved OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTs60W7g6F7Vg90H21EOLACvtfcHk0lhGZUoKLjNgaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVCjurY%253D&md5=8d27039287a98633d5daf21555217186</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.13.8925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.13.8925%26sid%3Dliteratum%253Aachs%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DSeeger%26aufirst%3DR.%2BC.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DAdkins%26aufirst%3DE.%2BS.%26aulast%3DHaas-Kogan%26aufirst%3DD.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DVillablanca%26aufirst%3DJ.%2BG.%26atitle%3DLong-term%2520results%2520for%2520children%2520with%2520high-risk%2520neuroblastoma%2520treated%2520on%2520a%2520randomized%2520trial%2520of%2520myeloablative%2520therapy%2520followed%2520by%252013-cis-retinoic%2520acid%253A%2520A%2520children%2527s%2520oncology%2520group%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D1007%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mills, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, R.</span><span> </span><span class="NLM_article-title">Adverse reactions to oral retinoids</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.2165%2F00002018-199309040-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8260121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fot12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1993&pages=280-290&author=C.+M.+Millsauthor=R.+Marks&title=Adverse+reactions+to+oral+retinoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse reactions to oral retinoids. An update</span></div><div class="casAuthors">Mills C M; Marks R</div><div class="citationInfo"><span class="NLM_cas:title">Drug safety</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">280-90</span>
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    </div><div class="casAbstract">Retinoids, both naturally occurring and synthetic, are analogues of vitamin A.  They represent a major advance in the treatment of acne and psoriasis, as well as rarer conditions such as the ichthyoses.  The more frequent and widespread use of these drugs requires that the dermatologist be aware of the wide spectrum of adverse events that may be encountered with their use.  Some are serious and irreversible, such as teratogenicity, necessitating great care if these drugs are given to women of childbearing potential.  Other effects may be less severe, dose dependent and reversible.  Although not devastating to the patient, appropriate advice may reduce morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPc4E2NTx3p-kdrW1FkXG-fW6udTcc2eYSyPpjNU76p7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fot12ksA%253D%253D&md5=5ebbca0af4632a2d451fcb2de674a5c6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F00002018-199309040-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199309040-00006%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DR.%26atitle%3DAdverse%2520reactions%2520to%2520oral%2520retinoids%26jtitle%3DDrug%2520Saf.%26date%3D1993%26volume%3D9%26spage%3D280%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Collins, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G. E.</span><span> </span><span class="NLM_article-title">Teratology of retinoids</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=399-430&author=M.+D.+Collinsauthor=G.+E.+Mao&title=Teratology+of+retinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DM.%2BD.%26aulast%3DMao%26aufirst%3DG.%2BE.%26atitle%3DTeratology%2520of%2520retinoids%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1999%26volume%3D39%26spage%3D399%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">White, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baetz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett-Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonasoro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilworth, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petkovich, M.</span><span> </span><span class="NLM_article-title">Identification of the retinoic acid-inducible all-<i>trans-</i>retinoic acid 4-hydroxylase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">29922</span><span class="NLM_x">–</span> <span class="NLM_lpage">29927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=29922-29927&author=J.+A.+Whiteauthor=Y.-D.+Guoauthor=K.+Baetzauthor=B.+Beckett-Jonesauthor=J.+Bonasoroauthor=K.+E.+Hsuauthor=F.+J.+Dilworthauthor=G.+Jonesauthor=M.+Petkovich&title=Identification+of+the+retinoic+acid-inducible+all-trans-retinoic+acid+4-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BA.%26aulast%3DGuo%26aufirst%3DY.-D.%26aulast%3DBaetz%26aufirst%3DK.%26aulast%3DBeckett-Jones%26aufirst%3DB.%26aulast%3DBonasoro%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DK.%2BE.%26aulast%3DDilworth%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DPetkovich%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520retinoic%2520acid-inducible%2520all-trans-retinoic%2520acid%25204-hydroxylase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D29922%26epage%3D29927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Steensel, M. A. M.</span><span> </span><span class="NLM_article-title">Retinoic acid metabolism blocking agents (RAMBAs): A new paradigm in the treatment of hyperkeratotic disorders</span> <span class="citation_source-journal">J. Dtsch. Dermatol. Ges.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1610-0387.2007.06541.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17941881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD1c3otFOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=355-365&author=C.+J.+Verfailleauthor=M.+Borgersauthor=M.+A.+M.+van+Steensel&title=Retinoic+acid+metabolism+blocking+agents+%28RAMBAs%29%3A+A+new+paradigm+in+the+treatment+of+hyperkeratotic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders</span></div><div class="casAuthors">Verfaille Christel J; Borgers Marcel; van Steensel Maurice A M</div><div class="citationInfo"><span class="NLM_cas:title">Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Synthetic vitamin A derivatives, retinoids,have long been the mainstay of treatment for several disorders of keratinization, notably the ichthyoses and severe acne.  Some forms of psoriasis also respond well.  Their considerable power comes at a price.  They have dose-limiting side effects and can be highly teratogenic, limiting their use in women of childbearing age.Thus, retinoids are used less often than their potential would warrant.  However, the recent development of compounds that block the catabolism of endogenous vitamin A, called Retinioic Acid Metabolism Blocking Agents or RAMBAs, offers new possibilities.  With these drugs, retinoid effects with less side effects and a reduction of the post-treatment teratogenicity period due to their favourable pharmacokinetic profile might be expected.  In this review, we discuss how retinoids work, how they are metabolized and how RAMBAs influence this process.  We also review the presently available data from clinical trials with RAMBAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3Z9_0N61oRoYPsCkJIw00fW6udTcc2eYSyPpjNU76p7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3otFOrtA%253D%253D&md5=34bfad7a80bac05641363ab7e184ca9b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1610-0387.2007.06541.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1610-0387.2007.06541.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3Dvan%2BSteensel%26aufirst%3DM.%2BA.%2BM.%26atitle%3DRetinoic%2520acid%2520metabolism%2520blocking%2520agents%2520%2528RAMBAs%2529%253A%2520A%2520new%2520paradigm%2520in%2520the%2520treatment%2520of%2520hyperkeratotic%2520disorders%26jtitle%3DJ.%2520Dtsch.%2520Dermatol.%2520Ges.%26date%3D2008%26volume%3D6%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Njar, V. C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gediya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purushottamachar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasaitis, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belosay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span> </span><span class="NLM_article-title">Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4323</span><span class="NLM_x">–</span> <span class="NLM_lpage">4340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4323-4340&author=V.+C.+O.+Njarauthor=L.+Gediyaauthor=P.+Purushottamacharauthor=P.+Chopraauthor=T.+S.+Vasaitisauthor=A.+Khandelwalauthor=J.+Mehtaauthor=C.+Huynhauthor=A.+Belosayauthor=J.+Patel&title=Retinoic+acid+metabolism+blocking+agents+%28RAMBAs%29+for+treatment+of+cancer+and+dermatological+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNjar%26aufirst%3DV.%2BC.%2BO.%26aulast%3DGediya%26aufirst%3DL.%26aulast%3DPurushottamachar%26aufirst%3DP.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DVasaitis%26aufirst%3DT.%2BS.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DJ.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DBelosay%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%26atitle%3DRetinoic%2520acid%2520metabolism%2520blocking%2520agents%2520%2528RAMBAs%2529%2520for%2520treatment%2520of%2520cancer%2520and%2520dermatological%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4323%26epage%3D4340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchet-Bardon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Steensel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steijlen, P. M.</span><span> </span><span class="NLM_article-title">Oral liarozole vs. acitretin in the treatment of ichthyosis: A phase II/III multicentre, double-blind, randomized, active-controlled study</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2133.2006.07745.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17263800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt12rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2007&pages=965-973&author=C.+J.+Verfailleauthor=F.+P.+Vanhoutteauthor=C.+Blanchet-Bardonauthor=M.+A.+van+Steenselauthor=P.+M.+Steijlen&title=Oral+liarozole+vs.+acitretin+in+the+treatment+of+ichthyosis%3A+A+phase+II%2FIII+multicentre%2C+double-blind%2C+randomized%2C+active-controlled+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study</span></div><div class="casAuthors">Verfaille, C. J.; Vanhoutte, F. P.; Blanchet-Bardon, C.; van Steense, M. A.; Steijlen, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">965-973</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Liarozole, a retinoic acid metab. blocking agent, has been granted orphan drug status for congenital ichthyosis by the European Commission and the U.S. Food and Drug Administration.  The purpose of this trial was to investigate the efficacy, tolerability and safety of oral liarozole vs. acitretin in patients with ichthyosis.  In this double-blind comparative trial of liarozole vs. acitretin, 32 patients with ichthyosis were randomized to be treated with either oral liarozole 75 mg in the morning and 75 mg in the evening or with acitretin 10 mg in the morning and 25 mg in the evening for 12 wk.  Clin. efficacy, tolerability and safety were monitored.  Between-group comparisons for efficacy and tolerability revealed no statistically significant differences except for scaling on the trunk at baseline which was significantly worse in the liarozole group (P = 0.024) and showed a more pronounced improvement in this group than in the acitretin-treated patients (P = 0.047).  Based on the overall evaluation of the response to treatment at end-point, 10 of 15 patients in the liarozole group and 13 of 16 patients in the acitretin group were considered by the investigator to be at least markedly improved.  The expected retinoic acid-related adverse events were mostly mild to moderate and tended to occur less frequently in the liarozole group.  No serious adverse events related to the drugs occurred.  The present study indicates that liarozole at a daily dose of 150 mg is equally effective as a treatment for ichthyosis as acitretin but shows a trend towards a more favorable tolerability profile.  The results of this trial warrant further clin. trials to confirm efficacy and safety of liarozole as an orphan drug in ichthyosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryTSUlmtVyWLVg90H21EOLACvtfcHk0lhy57rC0U0wLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt12rtrY%253D&md5=b20f5eeefc5284587e989c9cfda718da</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2006.07745.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2006.07745.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DVanhoutte%26aufirst%3DF.%2BP.%26aulast%3DBlanchet-Bardon%26aufirst%3DC.%26aulast%3Dvan%2BSteensel%26aufirst%3DM.%2BA.%26aulast%3DSteijlen%26aufirst%3DP.%2BM.%26atitle%3DOral%2520liarozole%2520vs.%2520acitretin%2520in%2520the%2520treatment%2520of%2520ichthyosis%253A%2520A%2520phase%2520II%252FIII%2520multicentre%252C%2520double-blind%252C%2520randomized%252C%2520active-controlled%2520study%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D156%26spage%3D965%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bryson, H. M.; Wagstaff, A. J.</span><span> </span><span class="NLM_article-title">Liarozole</span>.  <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">478484</span>, discussion 485.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.2165%2F00002512-199609060-00010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=478484&author=H.+M.+Bryson&author=A.+J.+Wagstaff&title=Liarozole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2165%2F00002512-199609060-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199609060-00010%26sid%3Dliteratum%253Aachs%26aulast%3DBryson%26aufirst%3DH.%2BM.%26atitle%3DLiarozole%26jtitle%3DDrugs%2520Aging%26date%3D1996%26volume%3D9%26spage%3D478484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thissen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovenschen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiljen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kerkhof, P. C. M.</span><span> </span><span class="NLM_article-title">Oral R115866 in the treatment of moderate to severe plaque-type psoriasis</span> <span class="citation_source-journal">J. Eur. Acad. Dermatol. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1468-3083.2007.02158.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17714122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD2svpsFeqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=1038-1046&author=C.+J.+Verfailleauthor=C.+A.+Thissenauthor=H.+J.+Bovenschenauthor=J.+Mertensauthor=P.+M.+Steiljenauthor=P.+C.+M.+van+de+Kerkhof&title=Oral+R115866+in+the+treatment+of+moderate+to+severe+plaque-type+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oral R115866 in the treatment of moderate to severe plaque-type psoriasis</span></div><div class="casAuthors">Verfaille C J; Thissen C A C B; Bovenschen H J; Mertens J; Steijlen P M; van de Kerkhof P C M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology : JEADV</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1038-46</span>
        ISSN:<span class="NLM_cas:issn">0926-9959</span>.
    </div><div class="casAbstract">BACKGROUND:  R115866 (Rambazole) is a new generation all-trans retinoic acid metabolism blocking agent, highly specific against the retinoic acid 4-hydroxylase.  The drug alleviates hyperproliferation and normalizes differentiation of the epidermis in animal models of psoriasis.  OBJECTIVE:  To explore the efficacy, safety and tolerability of systemic R115866 in patients with moderate to severe plaque-type psoriasis.  PATIENTS AND METHODS:  In this open label, single-arm trial, patients were treated with R115866, 1 mg/day for 8 weeks, followed by a 2-week treatment-free follow-up period.  Patients were monitored for efficacy and safety.  RESULTS:  Nineteen patients (intent-to-treat population) were treated and 14 completed the entire study.  Two patients discontinued due to lack of efficacy and three due to adverse events.  At the end of the treatment, 26% of the patients showed at least 50% reduction in Psoriasis Area Severity Index (PASI) compared to baseline.  Further improvement was observed at the end of the 2-week follow-up period where 47% of the patients showed a 50% or greater reduction in PASI.  Kinetic data showed no evidence of accumulation of either R115866 or retinoic acid in plasma.  The most common adverse events were pruritus, xerosis, cheilitis and an increase in blood triglycerides.  The majority of adverse events were mild to moderate.  No deaths or serious adverse events were reported.  CONCLUSION:  Eight-week daily treatment with 1 mg R115866 resulted in a significant reduction in PASI from baseline to end of therapy.  Additional improvement was seen after the 2-week follow-up period.  The drug was well tolerated.  R115866 merits further evaluation to optimize its clinical efficacy and safety profile in moderate to severe plaque-type psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu-YGceVFf4CnGiHuhFGv8fW6udTcc2ea3kiDBigEad7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpsFeqtg%253D%253D&md5=f0ede2958be29ce134445e86bcd2f711</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2007.02158.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2007.02158.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DThissen%26aufirst%3DC.%2BA.%26aulast%3DBovenschen%26aufirst%3DH.%2BJ.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DSteiljen%26aufirst%3DP.%2BM.%26aulast%3Dvan%2Bde%2BKerkhof%26aufirst%3DP.%2BC.%2BM.%26atitle%3DOral%2520R115866%2520in%2520the%2520treatment%2520of%2520moderate%2520to%2520severe%2520plaque-type%2520psoriasis%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2007%26volume%3D21%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roseeuw, D.</span><span> </span><span class="NLM_article-title">Oral R115866 in the treatment of moderate to severe facial acne vulgaris: An exploratory study</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2133.2007.07896.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17459036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovVOmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2007&pages=122-126&author=C.+J.+Verfailleauthor=M.+Coelauthor=I.+H.+Boersmaauthor=J.+Mertensauthor=M.+Borgersauthor=D.+Roseeuw&title=Oral+R115866+in+the+treatment+of+moderate+to+severe+facial+acne+vulgaris%3A+An+exploratory+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study</span></div><div class="casAuthors">Verfaille, C. J.; Coel, M.; Boersma, I. H.; Mertens, J.; Borgers, M.; Roseeuw, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-126</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: R115866 (Rambazole; barrier Therapeutics NV, Geel, Belgium), a new-generation retinoic acid metab.-blocking agent, is a nonretinoid compd. enhancing intracellularly the endogenous levels of all-trans-retinoic acid by blocking its catabolism.  By virtue of this property, and the proven pos. effects of retinoids in the treatment of acne, R115866 could potentially be a useful drug for acne.  Objectives: To explore the efficacy, safety and tolerability of systemic R115866 in male patients with moderate to severe facial acne vulgaris (at least 15 papules and/or pustules and at least two nodulocystic lesions).  Methods: In this exploratory trial, 17 patients were treated with oral R115866 1 mg once daily for 12 wk, followed by a 4-wk treatment-free period.  Results: At the end of treatment (week 12, n = 16) a mean redn. in inflammatory lesion count of 77·4% (P < 0·001), in noninflammatory lesion count of 58·3% (P < 0·001) and in total lesion count of 76·0% (P < 0·001) was obsd. as compared with baseline.  All lesion counts were significantly reduced from week 4 onwards.  Mild side-effects were reported occasionally.  Conclusions: The current data indicate that treatment with oral R115866 1 mg once daily for 12 wk in patients with moderate to severe facial acne vulgaris is efficacious and well tolerated and merits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGR6PycNmm4LVg90H21EOLACvtfcHk0lhy57rC0U0wLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovVOmtLg%253D&md5=4fa0aa460f2405f4e376159991083ab4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2007.07896.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2007.07896.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DCoel%26aufirst%3DM.%26aulast%3DBoersma%26aufirst%3DI.%2BH.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DRoseeuw%26aufirst%3DD.%26atitle%3DOral%2520R115866%2520in%2520the%2520treatment%2520of%2520moderate%2520to%2520severe%2520facial%2520acne%2520vulgaris%253A%2520An%2520exploratory%2520study%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D157%26spage%3D122%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Geria, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinfeld, N. S.</span><span> </span><span class="NLM_article-title">Talarazole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1228-1237&author=A.+N.+Geriaauthor=N.+S.+Scheinfeld&title=Talarazole%2C+a+selective+inhibitor+of+P450-mediated+all-trans+retinoic+acid+for+the+treatment+of+psoriasis+and+acne"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeria%26aufirst%3DA.%2BN.%26aulast%3DScheinfeld%26aufirst%3DN.%2BS.%26atitle%3DTalarazole%252C%2520a%2520selective%2520inhibitor%2520of%2520P450-mediated%2520all-trans%2520retinoic%2520acid%2520for%2520the%2520treatment%2520of%2520psoriasis%2520and%2520acne%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D9%26spage%3D1228%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Van Heusden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ginckel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruwiere, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Leede, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hove, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, W.</span><span> </span><span class="NLM_article-title">Inhibition of all-<i>trans</i>-retinoic acid metabolism by R116010 induces antitumour activity</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1038%2Fsj.bjc.6600056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=11870544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD38XislCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=605-611&author=J.+Van+Heusdenauthor=R.+Van+Ginckelauthor=H.+Bruwiereauthor=P.+Moelansauthor=B.+Janssenauthor=W.+Florenauthor=B.+J.+van+der+Leedeauthor=J.+van+Dunauthor=G.+Sanzauthor=M.+Venetauthor=L.+Dillenauthor=C.+Van+Hoveauthor=G.+Willemsensauthor=M.+Janicotauthor=W.+Wouters&title=Inhibition+of+all-trans-retinoic+acid+metabolism+by+R116010+induces+antitumour+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumor activity</span></div><div class="casAuthors">Van Heusden, J.; Van Ginckel, R.; Bruwiere, H.; Moelans, P.; Janssen, B.; Floren, W.; van der Leede, B. J.; van Dun, J.; Sanz, G.; Venet, M.; Dillen, L.; Van Hove, C.; Willemsens, G.; Janicot, M.; Wouters, W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">All-trans-retinoic acid is a potent inhibitor of cell proliferation and inducer of differentiation.  However, the clin. use of all-trans-retinoic acid in the treatment of cancer is significantly hampered by its toxicity and the prompt emergence of resistance, believed to be caused by increased all-trans-retinoic acid metab.  Inhibitors of all-trans-retinoic acid metab. may therefore prove valuable in the treatment of cancer.  In this study, we characterize R116010 as a new anticancer drug that is a potent inhibitor of all-trans-retinoic acid metab.  In vitro, R116010 potently inhibits all-trans-retinoic acid metab. in intact T47D cells with an IC50-value of 8.7 nM.  In addn., R116010 is a selective inhibitor as indicated by its inhibition profile for several other cytochrome P 450-mediated reactions.  In T47D cell proliferation assays, R116010 by itself has no effect on cell proliferation.  However, in combination with all-trans-retinoic acid, R116010 enhances the all-trans-retinoic acid-mediated antiproliferative activity in a concn.-dependent manner.  In vivo, the growth of murine estrogen-independent TA3-Ha mammary tumors is significantly inhibited by R116010 at doses as low as 0.16 mg kg-1.  In conclusion, R116010 is a highly potent and selective inhibitor of all-trans-retinoic acid metab., which is able to enhance the biol. activity of all-trans-retinoic acid, thereby exhibiting antitumor activity.  R116010 represents a novel and promising anticancer drug with an unique mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcR0XArGxYm7Vg90H21EOLACvtfcHk0lhsZ1QDFCJWBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislCmt7o%253D&md5=b34c02fa359e61af9ad63b6e5a6a52c1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600056%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHeusden%26aufirst%3DJ.%26aulast%3DVan%2BGinckel%26aufirst%3DR.%26aulast%3DBruwiere%26aufirst%3DH.%26aulast%3DMoelans%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DB.%26aulast%3DFloren%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BLeede%26aufirst%3DB.%2BJ.%26aulast%3Dvan%2BDun%26aufirst%3DJ.%26aulast%3DSanz%26aufirst%3DG.%26aulast%3DVenet%26aufirst%3DM.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DVan%2BHove%26aufirst%3DC.%26aulast%3DWillemsens%26aufirst%3DG.%26aulast%3DJanicot%26aufirst%3DM.%26aulast%3DWouters%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520all-trans-retinoic%2520acid%2520metabolism%2520by%2520R116010%2520induces%2520antitumour%2520activity%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D605%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span> </span><span class="NLM_article-title">Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1038%2Fsj.bjc.6603779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17486130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1675-1683&author=J.+L.+Armstrongauthor=A.+V.+Boddyauthor=C.+P.+F.+Redfernauthor=G.+J.+Veal&title=Molecular+targeting+of+retinoic+acid+metabolism+in+neuroblastoma%3A+the+role+of+the+CYP26+inhibitor+R116010+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targeting of retinoic acid metabolism in neuroblastoma: The role of the CYP26 inhibitor R116010 in vitro and in vivo</span></div><div class="casAuthors">Armstrong, J. L.; Taylor, G. A.; Thomas, H. D.; Boddy, A. V.; Redfern, C. P. F.; Veal, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1675-1683</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Isomerization to all-trans-retinoic acid (ATRA) is widely accepted as the key mechanism underlying the favorable clin. properties of 13-cis-retinoic acid (13cisRA).  As intracellular metab. of ATRA by CYP26 may result in clin. resistance to 13cisRA, an increase in efficacy may be achieved through modulation of this metabolic pathway.  We have evaluated the effect of the CYP26 inhibitor R116010 on retinoid metab. in neuroblastoma cell lines and a xenograft model.  In neuroblastoma cells, which showed a high level of CYP26 induction in response to ATRA, R116010 selectively inhibited ATRA metab.  In addn., siRNA-mediated knockdown of CYP26 selectively increased ATRA levels and the expression of retinoid-responsive marker genes was potentiated by R116010.  Treatment of mice bearing SH-SY5Y xenografts with 13cisRA (100 mg kg-1) revealed substantial levels (16%) of intratumoral ATRA after 6 h, despite plasma ATRA levels representing only 1% total retinoids under these conditions.  Co-administration of R116010 with 13cisRA in this mouse model resulted in significant increases in plasma ATRA and 13cisRA concns.  Furthermore, R116010 induced significant decreases in levels of 4-oxo metabolites in hepatic tissue after co-administration with either ATRA or 13cisRA.  These data suggest considerable potential for CYP26 inhibitors in the future treatment of neuroblastoma with 13cisRA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKjfql9mzZRrVg90H21EOLACvtfcHk0lhsZ1QDFCJWBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVShsbc%253D&md5=d8a5e451095172659c6c534d42d8ec2d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603779%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DBoddy%26aufirst%3DA.%2BV.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26atitle%3DMolecular%2520targeting%2520of%2520retinoic%2520acid%2520metabolism%2520in%2520neuroblastoma%253A%2520the%2520role%2520of%2520the%2520CYP26%2520inhibitor%2520R116010%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1675%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgens, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboraia, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): Synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101583w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2778-2791&author=M.+S.+Gomaaauthor=C.+E.+Bridgensauthor=A.+S.+Aboraiaauthor=G.+J.+Vealauthor=C.+P.+F.+Redfernauthor=A.+Brancaleauthor=J.+L.+Armstrongauthor=C.+Simons&title=Small+molecule+inhibitors+of+retinoic+acid+4-hydroxylase+%28CYP26%29%3A+Synthesis+and+biological+evaluation+of+imidazole+methyl+3-%284-%28aryl-2-ylamino%29phenyl%29propanoates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm101583w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101583w%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DBridgens%26aufirst%3DC.%2BE.%26aulast%3DAboraia%26aufirst%3DA.%2BS.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520retinoic%2520acid%25204-hydroxylase%2520%2528CYP26%2529%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520imidazole%2520methyl%25203-%25284-%2528aryl-2-ylamino%2529phenyl%2529propanoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2778%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobillon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-<i>trans</i> retinoic acid activity in neuroblastoma cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8301</span><span class="NLM_x">–</span> <span class="NLM_lpage">8313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8301-8313&author=M.+S.+Gomaaauthor=J.+L.+Armstrongauthor=B.+Bobillonauthor=G.+J.+Vealauthor=A.+Brancaleauthor=C.+P.+F.+Redfernauthor=C.+Simons&title=Novel+azolyl-%28phenylmethyl%29%5Daryl%2Fheteroarylamines%3A+Potent+CYP26+inhibitors+and+enhancers+of+all-trans+retinoic+acid+activity+in+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DBobillon%26aufirst%3DB.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DNovel%2520azolyl-%2528phenylmethyl%2529%255Daryl%252Fheteroarylamines%253A%2520Potent%2520CYP26%2520inhibitors%2520and%2520enhancers%2520of%2520all-trans%2520retinoic%2520acid%2520activity%2520in%2520neuroblastoma%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8301%26epage%3D8313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Keyser, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cock, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span> </span><span class="NLM_article-title">A versatile and convenient multigram syntheis of methylidenemalonic acid diesters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4859</span><span class="NLM_x">–</span> <span class="NLM_lpage">4862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=4859-4862&author=J.+L.+Keyserauthor=C.+J.+De+Cockauthor=J.+H.+Poupaertauthor=P.+Dumont&title=A+versatile+and+convenient+multigram+syntheis+of+methylidenemalonic+acid+diesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeyser%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BCock%26aufirst%3DC.%2BJ.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DDumont%26aufirst%3DP.%26atitle%3DA%2520versatile%2520and%2520convenient%2520multigram%2520syntheis%2520of%2520methylidenemalonic%2520acid%2520diesters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D4859%26epage%3D4862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bender, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol702892e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=509-511&author=D.+M.+Benderauthor=J.+A.+Petersonauthor=J.+R.+McCarthyauthor=H.+Gunaydinauthor=Y.+Takanoauthor=K.+N.+Houk&title=Cyclopropanecarboxylic+acid+esters+as+potential+prodrugs+with+enhanced+hydrolytic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fol702892e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol702892e%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DD.%2BM.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DCyclopropanecarboxylic%2520acid%2520esters%2520as%2520potential%2520prodrugs%2520with%2520enhanced%2520hydrolytic%2520stability%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D509%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paternak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicario, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span> </span><span class="NLM_article-title">Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070166b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2609-2611&author=L.+Yangauthor=G.+Butoraauthor=R.+X.+Jiaoauthor=A.+Paternakauthor=C.+Zhouauthor=W.+H.+Parsonsauthor=S.+G.+Millsauthor=P.+P.+Vicarioauthor=J.+M.+Ayalaauthor=M.+A.+Cascieriauthor=M.+Maccoss&title=Discovery+of+3-piperidinyl-1-cyclopentanecarboxamide+as+a+novel+scaffold+for+highly+potent+CC+chemokine+receptor+2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm070166b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070166b%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DButora%26aufirst%3DG.%26aulast%3DJiao%26aufirst%3DR.%2BX.%26aulast%3DPaternak%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DVicario%26aufirst%3DP.%2BP.%26aulast%3DAyala%26aufirst%3DJ.%2BM.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DMaccoss%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25203-piperidinyl-1-cyclopentanecarboxamide%2520as%2520a%2520novel%2520scaffold%2520for%2520highly%2520potent%2520CC%2520chemokine%2520receptor%25202%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2609%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Keliher, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobanian, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conkrite, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span> </span><span class="NLM_article-title">Efficient syntheses of four stable-isotope labeled (1<i>R</i>)-menthyl (1<i>S</i>,2<i>S</i>)-(+)-2-phenylcyclopropanecarboxylates</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=2777-2784&author=E.+J.+Keliherauthor=R.+C.+Burrellauthor=H.+R.+Chobanianauthor=K.+L.+Conkriteauthor=R.+Shuklaauthor=J.+E.+Baldwin&title=Efficient+syntheses+of+four+stable-isotope+labeled+%281R%29-menthyl+%281S%2C2S%29-%28%2B%29-2-phenylcyclopropanecarboxylates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeliher%26aufirst%3DE.%2BJ.%26aulast%3DBurrell%26aufirst%3DR.%2BC.%26aulast%3DChobanian%26aufirst%3DH.%2BR.%26aulast%3DConkrite%26aufirst%3DK.%2BL.%26aulast%3DShukla%26aufirst%3DR.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26atitle%3DEfficient%2520syntheses%2520of%2520four%2520stable-isotope%2520labeled%2520%25281R%2529-menthyl%2520%25281S%252C2S%2529-%2528%252B%2529-2-phenylcyclopropanecarboxylates%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D2777%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mattsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, S.</span><span> </span><span class="NLM_article-title">A mild hydrolysis of esters mediated by lithium salts</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2497</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2Fj.tetlet.2007.02.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2497-2499&author=S.+Mattssonauthor=M.+Dahlstromauthor=S.+Karlsson&title=A+mild+hydrolysis+of+esters+mediated+by+lithium+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A mild hydrolysis of esters mediated by lithium salts</span></div><div class="casAuthors">Mattsson, Sara; Dahlstroem, Mikael; Karlsson, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2497-2499</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">When treated with amine bases such as triethylamine and various lithium salts in wet solvents, esters are efficiently hydrolyzed to the corresponding acids in good yields.  Esters incorporating an α- or β-heteroatom with respect to the ester carbonyl group are hydrolyzed rapidly even at room temp.  To further demonstrate the usefulness of this method, one example is provided where hydrolysis of acetylated camphorsultam is mediated by LiBr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdhTIjsx0bVg90H21EOLACvtfcHk0ljvT982K-uLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D&md5=7a88787176f93ccdd555a0ab411b0635</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DS.%26aulast%3DDahlstrom%26aufirst%3DM.%26aulast%3DKarlsson%26aufirst%3DS.%26atitle%3DA%2520mild%2520hydrolysis%2520of%2520esters%2520mediated%2520by%2520lithium%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2497%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Han, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span> </span><span class="NLM_article-title">Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2069</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1210%2Fjc.81.6.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8964830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK28XjsFyksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=2069-2075&author=I.+S.+Hanauthor=J.+H.+Choi&title=Highly+specific+cytochrome+P450-like+enzymes+for+all-trans-retinoic+acid+in+T47D+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells</span></div><div class="casAuthors">Han, In Suk; Choi, Jee-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2069-2075</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">When human breast cancer T47D cells were treated with all-trans-retinoic acid (RA), the RA 4- and 18-hydroxylase activities were induced in microsomes in a time-dependent manner, indicating that these cells readily metabolized RA into more polar compds., such as all-trans-4-hydroxy-RA and all-trans-18-hydroxy-RA.  In contrast, T47D cells treated for 12 h with xenobiotics, such as phenobarbital, β-naphthoflavone, 3-methylcholanthrene, and DMSO, showed lower levels of catalytic activities for 4- and 18-hydroxylases.  The induction of 4- and 18-hydroxylase activities appears to be regulated at the level of transcriptional control (basal level).  Competitive assays demonstrated that inhibitors and substrates for 1A, 2A, 3A, 2B, and 2C cytochrome P 450 (P 450 subfamilies), all-trans-retinol, and all-trans-retinal showed no inhibition of RA metab., but other retinoic acid derivs. competed highly with RA.  The RA-inducible 4- and 18-hydroxylases showed high specificity for RA and high levels of catalytic activities, with Km and max. velocity values for 4-hydroxylase equal to 99 nmol/L and 0.26 pmol/min·mg protein, resp., and those for 18-hydroxylase equal to 65 nmol/L and 0.18 pmol/min·mg protein.  Cell-free metab. of RA required microsomes from RA-treated cells and NADPH, and was inhibited by liarozole, an inhibitor of P 450.  These data suggest that RA-inducible 4- and 18-hydroxylases may be novel P 450 isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod6bx0AQ05JbVg90H21EOLACvtfcHk0ljvT982K-uLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFyksr8%253D&md5=6532f8828e33fd4448002da0b3b3b147</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1210%2Fjc.81.6.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.81.6.2069%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DI.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26atitle%3DHighly%2520specific%2520cytochrome%2520P450-like%2520enzymes%2520for%2520all-trans-retinoic%2520acid%2520in%2520T47D%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1996%26volume%3D81%26spage%3D2069%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span> </span><span class="NLM_article-title">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1124%2Fdmd.105.004259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=15932954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1304-1311&author=R.+J.+Rileyauthor=D.+F.+McGinnityauthor=R.+P.+Austin&title=A+unified+model+for+predicting+human+hepatic%2C+metabolic+clearance+from+in+vitro+intrinsic+clearance+data+in+hepatocytes+and+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span></div><div class="casAuthors">Riley, Robert J.; McGinnity, D. F.; Austin, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1304-1311</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate a unified method for predicting human in vivo intrinsic clearance (CLint, in vivo) and hepatic clearance (CLh) from in vitro data in hepatocytes and microsomes by applying the unbound fraction in blood (fub) and in vitro incubations (fuinc).  Human CLint, in vivo was projected using in vitro data together with biol. scaling factors and compared with the unbound intrinsic clearance (CLint, ub, in vivo) estd. from clin. data using liver models with and without the various fu terms.  For incubations conducted with fetal calf serum (n = 14), the obsd. CLint, in vivo was modeled well assuming fuinc and fub were equiv.  CLint, ub, in vivo was predicted best using both fub and fuinc for other hepatocyte data (n = 56; r2 = 0.78, p = 3.3×10-19, av. fold error = 5.2).  A similar model for CLint, ub, in vivo was established for microsomal data (n = 37; r2 = 0.77, p = 1.2×10-12, av. fold error = 6.1).  Using the model for CLint, ub, in vivo (including a further empirical scaling factor), the CLh in humans was also calcd. according to the well stirred liver model for the most extensive dataset.  CLint, in vivo and CLh were both predicted well using in vitro human data from several labs. for acidic, basic, and neutral drugs.  The direct use of this model using only in vitro human data to predict the metabolic component of CLh is attractive, as it does not require extra information from preclin. studies in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrU05rRTm6LVg90H21EOLACvtfcHk0ljvT982K-uLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D&md5=79b80848977739267e4dd0ae82e5cbab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.004259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.004259%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26atitle%3DA%2520unified%2520model%2520for%2520predicting%2520human%2520hepatic%252C%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520intrinsic%2520clearance%2520data%2520in%2520hepatocytes%2520and%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1304%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbourne, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span> </span><span class="NLM_article-title">Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): Active site architecture and ligand binding</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1080%2F14756360600742014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17059167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=361-369&author=M.+S.+Gomaaauthor=S.+W.+Yeeauthor=C.+E.+Milbourneauthor=M.+C.+Barberaauthor=C.+Simonsauthor=A.+Brancale&title=Homology+model+of+human+retinoic+acid+metabolising+enzyme+cytochrome+P450+26A1+%28CYP26A1%29%3A+Active+site+architecture+and+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding</span></div><div class="casAuthors">Gomaa, Mohamed Sayed; Yee, Sook Wah; Milbourne, Ceri Elizabeth; Barbera, Maria Chiara; Simons, Claire; Brancale, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-369</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Homol. models of cytochrome P 450 RA1 (CYP26A1) were constructed using three human P 450 structures, CYP2C8, CYP2C9 and CYP3A4 as templates for the model building.  Using MOE software the lowest energy CYP26A1 model was then assessed for stereochem. quality and side chain environment.  Further active site optimization of the CYP26A1 model built using the CYP3A4 template was performed by mol. dynamics to generate a final CYP26A1 model.  The natural substrate, all-trans-retinoic acid (atRA), and inhibitor R115866, were docked into the model allowing further validation of the active site architecture.  Using the docking studies structurally and functionally important residues were identified with subsequent characterization of secondary structure.  Multiple hydrophobic interactions, including the side chains of Trp112, Phe299, Phe222, Phe84, Phe374 and Pro371, are important for binding of atRA and R115866.  Addnl. hydrogen bonding interactions were noted as follows: atRA - C=O of the atRA carboxylate group and Arg86; R115866 - benzothiazole nitrogen and the backbone NH of Ser115.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxHFbWHD55GbVg90H21EOLACvtfcHk0ljvT982K-uLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbM&md5=7b4c3b0ed018ca842395f2146c313d6e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F14756360600742014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600742014%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DMilbourne%26aufirst%3DC.%2BE.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26aulast%3DSimons%26aufirst%3DC.%26aulast%3DBrancale%26aufirst%3DA.%26atitle%3DHomology%2520model%2520of%2520human%2520retinoic%2520acid%2520metabolising%2520enzyme%2520cytochrome%2520P450%252026A1%2520%2528CYP26A1%2529%253A%2520Active%2520site%2520architecture%2520and%2520ligand%2520binding%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D361%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Perrin, D. D.; Armarengo, W. L. F.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Pergamon Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=D.+D.+Perrin&author=W.+L.+F.+Armarengo&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%2BD.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DPergamon%2520Press%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Molecular Operating Environment 2008.10 (MOE) Chemical Computing Group Inc Montreal Quebec Canada <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+2008.10+%28MOE%29+Chemical+Computing+Group+Inc+Montreal+Quebec+Canada+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stützle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span> <span class="citation_source-journal">Swarm Intell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1007%2Fs11721-007-0006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Korb%2C+O.%3B+St%C3%BCtzle%2C+T.%3B+Exner%2C+T.+E.Swarm+Intell.+2007%2C+1%2C+115%E2%80%93134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs11721-007-0006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11721-007-0006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26jtitle%3DSwarm%2520Intell.%26date%3D2007%26volume%3D1%26spage%3D115%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Spoel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drunen, R.</span><span> </span><span class="NLM_article-title">GROMACS: A message-passing parallel molecular dynamics implementation</span> <span class="citation_source-journal">Comput. Phys. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+van+der+Spoelauthor=R.+van+Drunen&title=GROMACS%3A+A+message-passing+parallel+molecular+dynamics+implementation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d5b2a7bab8b4b6a695b6bdb0b8fba7a0b2fbbbb9">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0lhCMmw0Nhrtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3Dvan%2BDrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520A%2520message-passing%2520parallel%2520molecular%2520dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lindahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Spoel, D.</span><span> </span><span class="NLM_article-title">GROMACS 3.0: A package for molecular simulation and trajectory analysis</span> <span class="citation_source-journal">J. Mol. Mod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1007%2Fs008940100045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVGjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=306-317&author=E.+Lindahlauthor=B.+Hessauthor=D.+van+der+Spoel&title=GROMACS+3.0%3A+A+package+for+molecular+simulation+and+trajectory+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 3.0: a package for molecular simulation and trajectory analysis</span></div><div class="casAuthors">Lindahl, Erik; Hess, Berk; van der Spoel, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling [online computer file]</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">GROMACS 3.0 is the latest release of a versatile and very well optimized package for mol. simulation.  Much effort has been devoted to achieving extremely high performance on both workstations and parallel comouters.  The design includes an extn. of virial and periodic boundary conditions from the loops over pairwise interactions, and special software routines to enable rapid calcn. of x-1/2.  Inner loops are generated automatically in C or Fortran at compile time, with optimizations adapted to each architecture.  Assembly loops using SSE and 3DNow! multimedia instructions are provided for x86 processors, resulting in exceptional performance on inexpensive PC workstations.  The interface is simple and easy to use, based on std. command line arguments with self-explanatory functionality and integrated documentation.  A large collection of flexible tools for trajectory anal. is included, with output in the form of finished Xmgr/Grace graphs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xBKmKIYW3bVg90H21EOLACvtfcHk0lhCMmw0Nhrtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVGjsL4%253D&md5=fca1fafdbbab2f42b3ab9c789b8a048e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs008940100045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs008940100045%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DE.%26aulast%3DHess%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26atitle%3DGROMACS%25203.0%253A%2520A%2520package%2520for%2520molecular%2520simulation%2520and%2520trajectory%2520analysis%26jtitle%3DJ.%2520Mol.%2520Mod.%26date%3D2001%26volume%3D7%26spage%3D306%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Humphrey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">VMD—Visual Molecular Dynamics</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2F0263-7855%2896%2900018-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8744570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK28Xis12nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=33-38&author=W.+Humphreyauthor=A.+Dalkeauthor=K.+Schulten&title=VMD%E2%80%94Visual+Molecular+Dynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">VDM: visual molecular dynamics</span></div><div class="casAuthors">Humphrey, William; Dalke, Andrew; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8, plates, 27-28</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">VMD is a mol. graphics program designed for the display and anal. of mol. assemblies, in particular, biopolymers such as proteins and nucleic acids.  VMD can simultaneously display any no. of structures using a wide variety of rendering styles and coloring methods.  Mols. are displayed as one or more "representations," in which each representation embodies a particular rendering method and coloring scheme for a selected subset of atoms.  The atoms displayed in each representation are chosen using an extensive atom selection syntax, which includes Boolean operators and regular expressions.  VMD provides a complete graphical user interface for program control, as well as a text interface using the Tcl embeddable parser to allow for complex scripts with variable substitution, control loops, and function calls.  Full session logging is supported, which produces a VMD command script for later playback.  High-resoln. raster images of displayed mols. may be produced by generating input scripts for use by a no. of photorealistic image-rendering applications.  VMD has also been expressly designed with the ability to animate mol. dynamics (MD) simulation trajectories, imported either from files or from a direct connection to a running MD simulation.  VMD is the visualization component of MDScope, a set of tools for interactive problem solving in structural biol., which also includes the parallel MD program NAMD, and the MDCOMM software used to connect the visualization and simulation programs, VMD is written in C++, using an object-oriented design; the program, including source code and extensive documentation, is freely available via anonymous ftp and through the World Wide Web.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dd54QvBO97Vg90H21EOLACvtfcHk0lhCMmw0Nhrtpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis12nsrg%253D&md5=1e3094ec3151fb85c5ff05f8505c78d5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2896%2900018-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252896%252900018-5%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DW.%26aulast%3DDalke%26aufirst%3DA.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DVMD%25E2%2580%2594Visual%2520Molecular%2520Dynamics%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1996%26volume%3D14%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Diaz</span>, <span class="hlFld-ContribAuthor ">Weize  Huang</span>, <span class="hlFld-ContribAuthor ">Charles M.  Keyari</span>, <span class="hlFld-ContribAuthor ">Brian  Buttrick</span>, <span class="hlFld-ContribAuthor ">Lauren  Price</span>, <span class="hlFld-ContribAuthor ">Nicolas  Guilloteau</span>, <span class="hlFld-ContribAuthor ">Sasmita  Tripathy</span>, <span class="hlFld-ContribAuthor ">Vanessa G.  Sperandio</span>, <span class="hlFld-ContribAuthor ">Frank R.  Fronczek</span>, <span class="hlFld-ContribAuthor ">Fanny  Astruc-Diaz</span>, and <span class="hlFld-ContribAuthor ">Nina  Isoherranen</span>  . </span><span class="cited-content_cbyCitation_article-title">Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2579-2595. <a href="https://doi.org/10.1021/acs.jmedchem.5b01780" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01780%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252BCharacterization%252Bof%252BNovel%252Band%252BSelective%252BInhibitors%252Bof%252BCytochrome%252BP450%252BCYP26A1%25252C%252Bthe%252BHuman%252BLiver%252BRetinoic%252BAcid%252BHydroxylase%26aulast%3DDiaz%26aufirst%3DPhilippe%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D13112015%26date%3D15032016%26date%3D24032016%26date%3D26022016%26volume%3D59%26issue%3D6%26spage%3D2579%26epage%3D2595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Dan A.  Rock</span>, <span class="hlFld-ContribAuthor ">Xiaogang  Han</span>, <span class="hlFld-ContribAuthor ">Robert A.  Flowers, II</span>, <span class="hlFld-ContribAuthor ">Larry C.  Wienkers</span>, and <span class="hlFld-ContribAuthor ">Jan L.  Wahlstrom</span>  . </span><span class="cited-content_cbyCitation_article-title">Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1205-1214. <a href="https://doi.org/10.1021/jm201346g" title="DOI URL">https://doi.org/10.1021/jm201346g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201346g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201346g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand-Based%252BDesign%252Bof%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BCytochrome%252BP450%252B2C19%26aulast%3DFoti%26aufirst%3DRobert%2BS.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D07102011%26date%3D31012012%26date%3D09022012%26date%3D12012012%26volume%3D55%26issue%3D3%26spage%3D1205%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maja  Bilip</span>, <span class="hlFld-ContribAuthor ">Shreya  Shah</span>, <span class="hlFld-ContribAuthor ">Mayuran  Mathiyalakan</span>, <span class="hlFld-ContribAuthor ">Aristides D.  Tagalakis</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Hart</span>, <span class="hlFld-ContribAuthor ">Ruhina  Maeshima</span>, <span class="hlFld-ContribAuthor ">Simon  Eaton</span>, <span class="hlFld-ContribAuthor ">Michael  Orford</span>, <span class="hlFld-ContribAuthor ">Elsa  Irving</span>, <span class="hlFld-ContribAuthor ">Alessia  Di Florio</span>, <span class="hlFld-ContribAuthor ">Claire  Simons</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stoker</span>. </span><span class="cited-content_cbyCitation_article-title">Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2020,</strong> <em>28 </em>
                                    (6)
                                     , 643-654. <a href="https://doi.org/10.1080/1061186X.2019.1710157" title="DOI URL">https://doi.org/10.1080/1061186X.2019.1710157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2019.1710157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2019.1710157%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DLiposomal%252Bdelivery%252Bof%252Bhydrophobic%252BRAMBAs%252Bprovides%252Bgood%252Bbioavailability%252Band%252Bsignificant%252Benhancement%252Bof%252Bretinoic%252Bacid%252Bsignalling%252Bin%252Bneuroblastoma%252Btumour%252Bcells%26aulast%3DBilip%26aufirst%3DMaja%26date%3D2020%26date%3D2020%26volume%3D28%26issue%3D6%26spage%3D643%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lindsay C.  Czuba</span>, <span class="hlFld-ContribAuthor ">Guo  Zhong</span>, <span class="hlFld-ContribAuthor ">King C.  Yabut</span>, <span class="hlFld-ContribAuthor ">Nina  Isoherranen</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of vitamin A and retinoids in biological matrices. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 309-340. <a href="https://doi.org/10.1016/bs.mie.2020.02.010" title="DOI URL">https://doi.org/10.1016/bs.mie.2020.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.mie.2020.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.mie.2020.02.010%26sid%3Dliteratum%253Aachs%26atitle%3DAnalysis%252Bof%252Bvitamin%252BA%252Band%252Bretinoids%252Bin%252Bbiological%252Bmatrices%26aulast%3DCzuba%26aufirst%3DLindsay%2BC.%26date%3D2020%26spage%3D309%26epage%3D340%26pub%3DElsevier%26atitle%3DRetinoid%252BSignaling%252BPathways%26date%3D2020%26volume%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Linfeng  Tian</span>, <span class="hlFld-ContribAuthor ">Shizhen  Zhao</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Yin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2016-2024. <a href="https://doi.org/10.1016/j.bmcl.2019.06.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bhighly%252Bselective%252Bcytochrome%252BP450%252Binhibitors%25253A%252BSeveral%252BCYP%252Btargets%252Bin%252Bcurrent%252Bresearch%26aulast%3DZhao%26aufirst%3DLiyu%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2016%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J  Spade</span>, <span class="hlFld-ContribAuthor ">Edward  Dere</span>, <span class="hlFld-ContribAuthor ">Susan J  Hall</span>, <span class="hlFld-ContribAuthor ">Christoph  Schorl</span>, <span class="hlFld-ContribAuthor ">Richard N  Freiman</span>, <span class="hlFld-ContribAuthor ">Kim  Boekelheide</span>. </span><span class="cited-content_cbyCitation_article-title">All-Trans Retinoic Acid Disrupts Development in
              Ex Vivo
              Cultured Fetal Rat Testes. I: Altered Seminiferous Cord Maturation and Testicular Cell Fate. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2019,</strong> <em>167 </em>
                                    (2)
                                     , 546-558. <a href="https://doi.org/10.1093/toxsci/kfy260" title="DOI URL">https://doi.org/10.1093/toxsci/kfy260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfy260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfy260%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DAll-Trans%252BRetinoic%252BAcid%252BDisrupts%252BDevelopment%252Bin%252BEx%252BVivo%252BCultured%252BFetal%252BRat%252BTestes.%252BI%25253A%252BAltered%252BSeminiferous%252BCord%252BMaturation%252Band%252BTesticular%252BCell%252BFate%26aulast%3DSpade%26aufirst%3DDaniel%2BJ%26date%3D2019%26date%3D2018%26volume%3D167%26issue%3D2%26spage%3D546%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Slobodan P.  Rendic</span>, <span class="hlFld-ContribAuthor ">F.  Peter Guengerich</span>. </span><span class="cited-content_cbyCitation_article-title">Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2018,</strong> <em>50 </em>
                                    (3)
                                     , 256-342. <a href="https://doi.org/10.1080/03602532.2018.1483401" title="DOI URL">https://doi.org/10.1080/03602532.2018.1483401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2018.1483401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2018.1483401%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DHuman%252Bcytochrome%252BP450%252Benzymes%252B5%2525E2%252580%25259351%252Bas%252Btargets%252Bof%252Bdrugs%252Band%252Bnatural%252Band%252Benvironmental%252Bcompounds%25253A%252Bmechanisms%25252C%252Binduction%25252C%252Band%252Binhibition%252B%2525E2%252580%252593%252Btoxic%252Beffects%252Band%252Bbenefits%26aulast%3DRendic%26aufirst%3DSlobodan%2BP.%26date%3D2018%26date%3D2018%26volume%3D50%26issue%3D3%26spage%3D256%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Barley</span>, <span class="hlFld-ContribAuthor ">Samir  Parekh</span>. </span><span class="cited-content_cbyCitation_article-title">Proteasome Inhibitors with a Focus on Bortezomib. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 45-71. <a href="https://doi.org/10.1007/978-3-319-75184-9_3" title="DOI URL">https://doi.org/10.1007/978-3-319-75184-9_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-75184-9_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-75184-9_3%26sid%3Dliteratum%253Aachs%26atitle%3DProteasome%252BInhibitors%252Bwith%252Ba%252BFocus%252Bon%252BBortezomib%26aulast%3DBarley%26aufirst%3DKevin%26date%3D2018%26date%3D2018%26spage%3D45%26epage%3D71%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DResistance%252Bof%252BTargeted%252BTherapies%252BExcluding%252BAntibodies%252Bfor%252BLymphomas%26aulast%3DFerreri%26aufirst%3DAndr%25C3%25A9s%2BJ.%2BM.%26date%3D2018%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hend A.A. Abd  El-wahab</span>, <span class="hlFld-ContribAuthor ">Mauro  Accietto</span>, <span class="hlFld-ContribAuthor ">Leonardo B.  Marino</span>, <span class="hlFld-ContribAuthor ">Kirsty J.  McLean</span>, <span class="hlFld-ContribAuthor ">Colin W.  Levy</span>, <span class="hlFld-ContribAuthor ">Hamdy M.  Abdel-Rahman</span>, <span class="hlFld-ContribAuthor ">Mahmoud A.  El-Gendy</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Munro</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Aboraia</span>, <span class="hlFld-ContribAuthor ">Claire  Simons</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (1)
                                     , 161-176. <a href="https://doi.org/10.1016/j.bmc.2017.11.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bagainst%252BMycobacterium%252Btuberculosis%252Bof%252Bazole%252Bpiperazine%252Bderivatives%252Bas%252Bdicyclotyrosine%252B%252528cYY%252529%252Bmimics%26aulast%3DEl-wahab%26aufirst%3DHend%2BA.A.%2BAbd%26date%3D2018%26volume%3D26%26issue%3D1%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imran  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammad Nadeem  Lone</span>, <span class="hlFld-ContribAuthor ">Haasan Y.  Aboul-Enein</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazoles as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1742-1773. <a href="https://doi.org/10.1039/C7MD00067G" title="DOI URL">https://doi.org/10.1039/C7MD00067G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00067G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00067G%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DImidazoles%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DAli%26aufirst%3DImran%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D1742%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. S.  Foti</span>, <span class="hlFld-ContribAuthor ">N.  Isoherranen</span>, <span class="hlFld-ContribAuthor ">A.  Zelter</span>, <span class="hlFld-ContribAuthor ">L. J.  Dickmann</span>, <span class="hlFld-ContribAuthor ">B. R.  Buttrick</span>, <span class="hlFld-ContribAuthor ">P.  Diaz</span>, <span class="hlFld-ContribAuthor ">D.  Douguet</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>357 </em>
                                    (2)
                                     , 281-292. <a href="https://doi.org/10.1124/jpet.116.232637" title="DOI URL">https://doi.org/10.1124/jpet.116.232637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.232637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.232637%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DIdentification%252Bof%252BTazarotenic%252BAcid%252Bas%252Bthe%252BFirst%252BXenobiotic%252BSubstrate%252Bof%252BHuman%252BRetinoic%252BAcid%252BHydroxylase%252BCYP26A1%252Band%252BCYP26B1%26aulast%3DFoti%26aufirst%3DR.%2BS.%26date%3D2016%26date%3D2016%26volume%3D357%26issue%3D2%26spage%3D281%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Shuai  Song</span>, <span class="hlFld-ContribAuthor ">Chen-Zhou  Hao</span>, <span class="hlFld-ContribAuthor ">Wan-Xu  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Chi  Liu</span>, <span class="hlFld-ContribAuthor ">Hong-Lei  Xie</span>, <span class="hlFld-ContribAuthor ">Bin  Lin</span>, <span class="hlFld-ContribAuthor ">Mao-Sheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular recognition of CYP26A1 binding pockets and structure–activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2015,</strong> <em>56 </em>, 10-19. <a href="https://doi.org/10.1016/j.jmgm.2014.11.014" title="DOI URL">https://doi.org/10.1016/j.jmgm.2014.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2014.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2014.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DMolecular%252Brecognition%252Bof%252BCYP26A1%252Bbinding%252Bpockets%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bfor%252Bdesign%252Bof%252Bpotent%252Band%252Bselective%252Bretinoic%252Bacid%252Bmetabolism%252Bblocking%252Bagents%26aulast%3DSun%26aufirst%3DBin%26date%3D2015%26volume%3D56%26spage%3D10%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Peter  Guengerich</span>. </span><span class="cited-content_cbyCitation_article-title">Human Cytochrome P450 Enzymes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 523-785. <a href="https://doi.org/10.1007/978-3-319-12108-6_9" title="DOI URL">https://doi.org/10.1007/978-3-319-12108-6_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-12108-6_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-12108-6_9%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%252BCytochrome%252BP450%252BEnzymes%26aulast%3DGuengerich%26aufirst%3DF.%2BPeter%26date%3D2015%26date%3D2015%26spage%3D523%26epage%3D785%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCytochrome%252BP450%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DPaul%2BR.%26date%3D2015%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faith  Stevison</span>, <span class="hlFld-ContribAuthor ">Jing  Jing</span>, <span class="hlFld-ContribAuthor ">Sasmita  Tripathy</span>, <span class="hlFld-ContribAuthor ">Nina  Isoherranen</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 373-412. <a href="https://doi.org/10.1016/bs.apha.2015.04.006" title="DOI URL">https://doi.org/10.1016/bs.apha.2015.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2015.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2015.04.006%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BRetinoic%252BAcid-Metabolizing%252BCytochrome%252BP450s%25252C%252BCYP26%25252C%252Bin%252BInflammation%252Band%252BCancer%26aulast%3DStevison%26aufirst%3DFaith%26date%3D2015%26spage%3D373%26epage%3D412%26pub%3DElsevier%26atitle%3DCytochrome%252BP450%252BFunction%252Band%252BPharmacological%252BRoles%252Bin%252BInflammation%252Band%252BCancer%26date%3D2015%26volume%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Pardo-Martin</span>, <span class="hlFld-ContribAuthor ">Amin  Allalou</span>, <span class="hlFld-ContribAuthor ">Jaime  Medina</span>, <span class="hlFld-ContribAuthor ">Peter M.  Eimon</span>, <span class="hlFld-ContribAuthor ">Carolina  Wählby</span>, <span class="hlFld-ContribAuthor ">Mehmet  Fatih Yanik</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput hyperdimensional vertebrate phenotyping. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms2475" title="DOI URL">https://doi.org/10.1038/ncomms2475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms2475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms2475%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DHigh-throughput%252Bhyperdimensional%252Bvertebrate%252Bphenotyping%26aulast%3DPardo-Martin%26aufirst%3DCarlos%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed S.  Gomaa</span>, <span class="hlFld-ContribAuthor ">Andrew S.T.  Lim</span>, <span class="hlFld-ContribAuthor ">S.C.  Wilson Lau</span>, <span class="hlFld-ContribAuthor ">Ann-Marie  Watts</span>, <span class="hlFld-ContribAuthor ">Nicola A.  Illingworth</span>, <span class="hlFld-ContribAuthor ">Caroline E.  Bridgens</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Veal</span>, <span class="hlFld-ContribAuthor ">Christopher P.F.  Redfern</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Jane L.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Claire  Simons</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (20)
                                     , 6080-6088. <a href="https://doi.org/10.1016/j.bmc.2012.08.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.08.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.08.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BCYP26A1%252Binhibitory%252Bactivity%252Bof%252Bnovel%252Bmethyl%252B3-%25255B4-%252528arylamino%252529phenyl%25255D-3-%252528azole%252529-2%25252C2-dimethylpropanoates%26aulast%3DGomaa%26aufirst%3DMohamed%2BS.%26date%3D2012%26volume%3D20%26issue%3D20%26spage%3D6080%26epage%3D6088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua F.  Robinson</span>, <span class="hlFld-ContribAuthor ">Elisa C.M.  Tonk</span>, <span class="hlFld-ContribAuthor ">Aart  Verhoef</span>, <span class="hlFld-ContribAuthor ">Aldert H.  Piersma</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole induced concentration-related gene signatures in rat whole embryo culture. </span><span class="cited-content_cbyCitation_journal-name">Reproductive Toxicology</span><span> <strong>2012,</strong> <em>34 </em>
                                    (2)
                                     , 275-283. <a href="https://doi.org/10.1016/j.reprotox.2012.05.088" title="DOI URL">https://doi.org/10.1016/j.reprotox.2012.05.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.reprotox.2012.05.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.reprotox.2012.05.088%26sid%3Dliteratum%253Aachs%26jtitle%3DReproductive%2520Toxicology%26atitle%3DTriazole%252Binduced%252Bconcentration-related%252Bgene%252Bsignatures%252Bin%252Brat%252Bwhole%252Bembryo%252Bculture%26aulast%3DRobinson%26aufirst%3DJoshua%2BF.%26date%3D2012%26volume%3D34%26issue%3D2%26spage%3D275%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed S.  Gomaa</span>, <span class="hlFld-ContribAuthor ">Caroline E.  Bridgens</span>, <span class="hlFld-ContribAuthor ">Nicola A.  Illingworth</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Veal</span>, <span class="hlFld-ContribAuthor ">Christopher P.F.  Redfern</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Jane L.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Claire  Simons</span>. </span><span class="cited-content_cbyCitation_article-title">Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (14)
                                     , 4201-4207. <a href="https://doi.org/10.1016/j.bmc.2012.05.076" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.05.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.05.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.05.076%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bretinoic%252Bacid%252B4-hydroxylase%252B%252528CYP26%252529%252Binhibitors%252Bbased%252Bon%252Ba%252B3-%2525281H-imidazol-%252Band%252Btriazol-1-yl%252529-2%25252C2-dimethyl-3-%2525284-%252528phenylamino%252529phenyl%252529propyl%252Bscaffold%26aulast%3DGomaa%26aufirst%3DMohamed%2BS.%26date%3D2012%26volume%3D20%26issue%3D14%26spage%3D4201%26epage%3D4207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RAMBAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development of compounds through SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) KOH, EtOH, reflux, 72 h. (ii) 1 N aqueous HCl, 64%. (iii) RBr, DMF, 80 °C, 2 h, 57–71%. (iv) EDC, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, room temperature and then R<sup>1</sup>R<sup>2</sup>NH, room temperature, overnight, 61–75%. (v) LiAlH<sub>4</sub>, THF, 0 °C, 1 h and then room temperature overnight, 79%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1,1′-Carbonylditriazole, triazole, CH<sub>3</sub>CN, reflux, 16 h, 63%. (ii) LiOH, THF, H<sub>2</sub>O, 20 h, reflux and then (iii) aqueous 1 N HCl 77%. (iv) EDC, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, room temperature and then CH<sub>3</sub>NH<sub>2</sub>, room temperature, overnight, 63%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Real-time PCR analysis of CYP26A1 mRNA expression after treatment with ATRA in combination with liarozole (Liar.), R116010 (R116), <b>2</b>, <b>5</b>, <b>10</b>, <b>11</b>, <b>15</b>, and <b>17</b>. SH-SY5Y cells were treated with ATRA alone (0.01–1 μM) or with ATRA (0.1 μM) in combination with inhibitor (1 μM) for 72 h. Total RNA was isolated, reverse transcribed, and subjected to real-time PCR using TaqMan probes for CYP26A1 and β-actin. Values were normalized for β-actin levels and expressed as a fold increase relative to CYP26A1 expression in SH-SY5Y cells treated with 0.01 μM ATRA. Data are mean values ± SDs (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Putative binding mode for <b>17</b>. The Fe atom of the heme is shown as a green sphere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/medium/jm-2011-00695m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Optimal SAR for the 2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl) propyl azole derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-19/jm200695m/production/images/large/jm-2011-00695m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200695m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gudas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Retinoids regulate stem cell differentiation</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1002%2Fjcp.22417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=20836077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2011&pages=322-330&author=L.+J.+Gudasauthor=J.+A.+Wagner&title=Retinoids+regulate+stem+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoids regulate stem cell differentiation</span></div><div class="casAuthors">Gudas, Lorraine J.; Wagner, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-330</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Retinoids are ubiquitous signaling mols. that influence nearly every cell type, exert profound effects on development, and complement cancer chemotherapeutic regimens.  All-trans retinoic acid (RA) and other active retinoids are generated from vitamin A (retinol), but key aspects of the signaling pathways required to produce active retinoids remain unclear.  Retinoids generated by one cell type can affect nearby cells, so retinoids also function in intercellular communication.  RA induces differentiation primarily by binding to RARs, transcription factors that assoc. with RXRs and bind RAREs in the nucleus.  Binding of RA: (1) initiates changes in interactions of RAR/RXRs with co-repressor and co-activator proteins, activating transcription of primary target genes; (2) alters interactions with proteins that induce epigenetic changes; (3) induces transcription of genes encoding transcription factors and signaling proteins that further modify gene expression (e.g., FOX03A, Hoxa1, Sox9, TRAIL, UBE2D3); and (4) results in alterations in estrogen receptor α signaling.  Proteins that bind at or near RAREs include Sin3a, N-CoR1, PRAME, Trim24, NRIP1, Ajuba, Zfp423, and MN1/TEL.  Interactions among retinoids, RARs/RXRs, and these proteins explain in part the powerful effects of retinoids on stem cell differentiation.  Studies of this retinol signaling cascade enhance our ability to understand and regulate stem cell differentiation for therapeutic and scientific purposes.  In cancer chemotherapeutic regimens retinoids can promote tumor cell differentiation and/or induce proteins that sensitize tumors to drug combinations.  Mechanistic studies of retinoid signaling continue to suggest novel drug targets and will improve therapeutic strategies for cancer and other diseases, such as immune-mediated inflammatory diseases.  J. Cell. Physiol. 226: 322-330, 2011. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1IVNhZBJYLVg90H21EOLACvtfcHk0lg6s4J8pjzjTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOkt7vI&md5=ec15d60914270bd1ac767db3e0d4a976</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22417%26sid%3Dliteratum%253Aachs%26aulast%3DGudas%26aufirst%3DL.%2BJ.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DRetinoids%2520regulate%2520stem%2520cell%2520differentiation%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D226%26spage%3D322%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fields, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soprano, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soprano, K. J.</span><span> </span><span class="NLM_article-title">Retinoids in biological control and cancer</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=886-898&author=A.+L.+Fieldsauthor=D.+R.+Sopranoauthor=K.+J.+Soprano&title=Retinoids+in+biological+control+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DA.%2BL.%26aulast%3DSoprano%26aufirst%3DD.%2BR.%26aulast%3DSoprano%26aufirst%3DK.%2BJ.%26atitle%3DRetinoids%2520in%2520biological%2520control%2520and%2520cancer%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D886%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Orfanos, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouboulis, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond-Roesler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geilen, C. C.</span><span> </span><span class="NLM_article-title">Current use and future potential role of retinoids in dermatology</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=358-388&author=C.+E.+Orfanosauthor=C.+C.+Zouboulisauthor=B.+Almond-Roeslerauthor=C.+C.+Geilen&title=Current+use+and+future+potential+role+of+retinoids+in+dermatology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrfanos%26aufirst%3DC.%2BE.%26aulast%3DZouboulis%26aufirst%3DC.%2BC.%26aulast%3DAlmond-Roesler%26aufirst%3DB.%26aulast%3DGeilen%26aufirst%3DC.%2BC.%26atitle%3DCurrent%2520use%2520and%2520future%2520potential%2520role%2520of%2520retinoids%2520in%2520dermatology%26jtitle%3DDrugs%26date%3D1997%26volume%3D53%26spage%3D358%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fritsch, P. O.</span><span> </span><span class="NLM_article-title">Retinoids in psoriasis and disorders of keratinization</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S8</span><span class="NLM_x">–</span> <span class="NLM_lpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1992&pages=S8-S14&author=P.+O.+Fritsch&title=Retinoids+in+psoriasis+and+disorders+of+keratinization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFritsch%26aufirst%3DP.%2BO.%26atitle%3DRetinoids%2520in%2520psoriasis%2520and%2520disorders%2520of%2520keratinization%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D1992%26volume%3D27%26spage%3DS8%26epage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Thielitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautheim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollnick, H.</span><span> </span><span class="NLM_article-title">Update in retinoid therapy of acne</span> <span class="citation_source-journal">Dermatol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1529-8019.2006.00084.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17014482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD28rosV2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=272-279&author=A.+Thielitzauthor=A.+Krautheimauthor=H.+Gollnick&title=Update+in+retinoid+therapy+of+acne"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Update in retinoid therapy of acne</span></div><div class="casAuthors">Thielitz Anja; Krautheim Andrea; Gollnick Harald</div><div class="citationInfo"><span class="NLM_cas:title">Dermatologic therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">272-9</span>
        ISSN:<span class="NLM_cas:issn">1396-0296</span>.
    </div><div class="casAbstract">The pathogenesis of acne, the most common skin disease, is complex and multifactorial.  Clinical experience has demonstrated that parallel targeting of various pathogenetic factors, achieved either by mono- or combination therapy with appropriate drugs, represents the most effective approach to treating acne.  Topical retinoids have been shown to expulse mature comedones, reduce microcomedone formation, and exert immunomodulatory effects.  They have broad anti-acne activity without the risk of inducing bacterial resistance, which justifies their use as first-line treatment in most types of noninflammatory and inflammatory acne and makes them uniquely suitable as long-term medication to maintain remission after cessation of initial combination therapy.  Systemic isotretinoin as a monotherapeutic agent strongly affects all four major pathogenetic factors and has been, in the hand of experienced dermatologists, a potent and safe agent for the treatment of severe and recalcitrant acne forms for more that 20 years.  However, patient counseling, careful monitoring, and evaluation and management of adverse events are necessary.  The use of isotretinoin has experienced a drawback now that its indication has been lowered from a first-line to a second-line medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxWKerTm1WqjToTC3aBaesfW6udTcc2eZjO7RR-CPNorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rosV2nsg%253D%253D&md5=bdb1f7115ad68812e2c33dde59e16dd1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1529-8019.2006.00084.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1529-8019.2006.00084.x%26sid%3Dliteratum%253Aachs%26aulast%3DThielitz%26aufirst%3DA.%26aulast%3DKrautheim%26aufirst%3DA.%26aulast%3DGollnick%26aufirst%3DH.%26atitle%3DUpdate%2520in%2520retinoid%2520therapy%2520of%2520acne%26jtitle%3DDermatol.%2520Ther.%26date%3D2006%26volume%3D19%26spage%3D272%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brecher, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlow, S. J.</span><span> </span><span class="NLM_article-title">Oral retinoid therapy for dermatological conditions in children and adolescents</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1067%2FS0190-9622%2803%2901564-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=12894062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD3szmtVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=171-182&author=A.+R.+Brecherauthor=S.+J.+Orlow&title=Oral+retinoid+therapy+for+dermatological+conditions+in+children+and+adolescents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Oral retinoid therapy for dermatologic conditions in children and adolescents</span></div><div class="casAuthors">Brecher Alexandra R; Orlow Seth J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-82; quiz 183-6</span>
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    </div><div class="casAbstract">The efficacy of systemic retinoid therapy in a number of dermatologic diseases is well established; however, concerns about potential side effects limit their use, especially in children.  We review the efficacy and toxicity of oral retinoids in the pediatric population.  The acute mucocutaneous toxicities commonly observed are typically well tolerated, readily treatable, and reversible.  Systemic toxicities include teratogenicity and effects on the musculoskeletal, neurologic, and gastrointestinal systems.  Children, like adults, generally tolerate short-term retinoid therapy without major complications.  Concerns regarding serious systemic side effects are greater for those on high doses of oral synthetic retinoids for longer periods of time.  Close patient monitoring and patient education can minimize the occurrence of complications. (J Am Acad Dermatol 2003;49:171-82.)Learning objective At the conclusion of this learning activity, participants should be familiar with use of oral retinoids for childhood dermatologic conditions such as psoriasis, acne, and ichthyoses as well as safety and risks associated with oral retinoid use in children and adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRCD0a7bwSaCSm0e6ZOaemfW6udTcc2eZpl9xofdtSK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szmtVKjsw%253D%253D&md5=29d080e6e2ab84272580cbf4d1963aa1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1067%2FS0190-9622%2803%2901564-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252FS0190-9622%252803%252901564-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrecher%26aufirst%3DA.%2BR.%26aulast%3DOrlow%26aufirst%3DS.%2BJ.%26atitle%3DOral%2520retinoid%2520therapy%2520for%2520dermatological%2520conditions%2520in%2520children%2520and%2520adolescents%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2003%26volume%3D49%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sanz, M. A.</span><span> </span><span class="NLM_article-title">Treatment of acute promyelocytic leukemia</span> <span class="citation_source-journal">Hematol. Am. Soc. Hematol. Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1182%2Fasheducation-2006.1.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17124054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD28nosFygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=147-155&author=M.+A.+Sanz&title=Treatment+of+acute+promyelocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of acute promyelocytic leukemia</span></div><div class="casAuthors">Sanz Miguel A</div><div class="citationInfo"><span class="NLM_cas:title">Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-55</span>
        ISSN:<span class="NLM_cas:issn">1520-4391</span>.
    </div><div class="casAbstract">Cure of acute promyelocytic leukemia (APL) is now a possibility for most patients through the use of state-of-the-art treatments, which include simultaneous administration of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy for induction and consolidation, as well as ATRA-based maintenance.  Risk-adapted strategies to modulate treatment intensity may be an effective approach to minimize therapy-related morbidity and mortality while maintaining the potential of cure.  In this context, there is no role for hematopoietic stem cell transplantation (HSCT) in front-line therapy, except for the small fraction of patients with persistent minimal residual disease at the end of consolidation.  However, HSCT plays an important role for patients in second complete remission.  In contrast, an increasing role of arsenic trioxide (ATO) is emerging.  Given the high antileukemic efficacy observed with ATO in patients relapsing after ATRA-containing regimens, this agent is currently regarded as the best treatment option in this setting.  However, until a randomized comparison between the standard therapy and ATO-based regimens in front-line therapy is available, this latter approach should only be recommended for unfit patients for whom chemotherapy is contraindicated.  In addition to reviewing current consensus and controversial issues on antileukemic strategies, this review addresses other aspects that can be crucial for the outcome of individual patients.  These aspects include supportive care, recognition and treatment of life-threatening complications, evaluation of response, and, finally, management of the disease in special conditions such as older patients, children and pregnant women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgiTy_lAvZN-98rul4nhSdfW6udTcc2eZpl9xofdtSK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nosFygug%253D%253D&md5=24a807dab9f5e7c4293fc13c7f300d53</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2006.1.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2006.1.147%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DM.%2BA.%26atitle%3DTreatment%2520of%2520acute%2520promyelocytic%2520leukemia%26jtitle%3DHematol.%2520Am.%2520Soc.%2520Hematol.%2520Educ.%2520Program%26date%3D2006%26spage%3D147%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Imaizumi, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kigasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horibe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukimoto, I.</span><span> </span><span class="NLM_article-title">Prospective study of a therapeutic regimen with all-<i>trans</i> retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2141.2010.08332.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=20735397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=89-98&author=M+Imaizumiauthor=A+Tawaauthor=R.+Hanadaauthor=M.+Tsuchidaauthor=K.+Tabuchiauthor=H.+Kigasawaauthor=R.+Kobayashiauthor=A.+Morimotoauthor=H.+Nakayamaauthor=K.+Hamamotoauthor=K.+Kudoauthor=H.+Yabeauthor=K.+Horibeauthor=S.+Tsuchiyaauthor=I.+Tsukimoto&title=Prospective+study+of+a+therapeutic+regimen+with+all-trans+retinoic+acid+and+anthracyclines+in+combination+of+cytarabine+in+children+with+acute+promyelocytic+leukaemia%3A+The+Japanese+childhood+acute+myeloid+leukaemia+cooperative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study</span></div><div class="casAuthors">Imaizumi, Masue; Tawa, Akio; Hanada, Ryoji; Tsuchida, Masahiro; Tabuchi, Ken; Kigasawa, Hisato; Kobayashi, Ryoji; Morimoto, Akira; Nakayama, Hideki; Hamamoto, Kazuko; Kudo, Kazuko; Yabe, Hiromasa; Horibe, Keizo; Tsuchiya, Shigeru; Tsukimoto, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In childhood acute promyelocytic leukemia (APL), the efficacy of therapy combining cytarabine with all-trans retinoic acid (ATRA) and anthracyclines remains unclear in terms of long-term prognosis.  Between August 1997 and March 2004, 58 children with APL (median age: 11 years) were enrolled into an acute myeloid leukemia (AML) study (AML99-M3) and followed up for a median time of 86 mo.  The regimen included ATRA and anthracyclines combined with cytarabine in both induction and consolidation.  In induction, two patients died of hemorrhage and four patients developed retinoic acid syndrome.  Of 58 patients, 56 (96.6%) achieved complete remission, two of whom relapsed in the bone marrow after 15 and 19 mo resp.  Sepsis was a major complication, with an incidence of 5.6-10.9% in the consolidation blocks, from which all but one of patients recovered.  Consequently, 7-yr overall and event-free survival rates were 93.1% and 91.4% resp., and cumulative incidence of relapse plateaued at 3.6% after 2 years.  Follow-up survey of 54 patients revealed no patients with late cardiotoxicity or secondary malignancy, except one with asymptomatic prolongation of QTc interval.  This study suggests that the combination of cytarabine with ATRA and anthracycline-based therapy may have useful implications in the perspective of long-term prognosis and late adverse effects for childhood APL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlzzOAV4lE-LVg90H21EOLACvtfcHk0lhdRiuK6Q4-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GlsL0%253D&md5=31f7d88176e001a94b183fa4bfa84776</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2010.08332.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2010.08332.x%26sid%3Dliteratum%253Aachs%26aulast%3DImaizumi%26aufirst%3DM%26aulast%3DTawa%26aufirst%3DA%26aulast%3DHanada%26aufirst%3DR.%26aulast%3DTsuchida%26aufirst%3DM.%26aulast%3DTabuchi%26aufirst%3DK.%26aulast%3DKigasawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DR.%26aulast%3DMorimoto%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DHamamoto%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DK.%26aulast%3DYabe%26aufirst%3DH.%26aulast%3DHoribe%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTsukimoto%26aufirst%3DI.%26atitle%3DProspective%2520study%2520of%2520a%2520therapeutic%2520regimen%2520with%2520all-trans%2520retinoic%2520acid%2520and%2520anthracyclines%2520in%2520combination%2520of%2520cytarabine%2520in%2520children%2520with%2520acute%2520promyelocytic%2520leukaemia%253A%2520The%2520Japanese%2520childhood%2520acute%2520myeloid%2520leukaemia%2520cooperative%2520study%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2011%26volume%3D152%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Matthay, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas-Kogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villablanca, J. G.</span><span> </span><span class="NLM_article-title">Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1200%2FJCO.2007.13.8925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=19171716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVCjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1007-1013&author=K.+K.+Matthayauthor=C.+P.+Reynoldsauthor=R.+C.+Seegerauthor=H.+Shimadaauthor=E.+S.+Adkinsauthor=D.+Haas-Koganauthor=R.+B.+Gerbingauthor=W.+B.+Londonauthor=J.+G.+Villablanca&title=Long-term+results+for+children+with+high-risk+neuroblastoma+treated+on+a+randomized+trial+of+myeloablative+therapy+followed+by+13-cis-retinoic+acid%3A+A+children%27s+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study</span></div><div class="casAuthors">Matthay, Katherine K.; Reynolds, C. Patrick; Seeger, Robert C.; Shimada, Hiroyuki; Adkins, E. Stanton; Haas-Kogan, Daphne; Gerbing, Robert B.; London, Wendy B.; Villablanca, Judith G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: We assessed the long-term outcome of patients enrolled on CCG-3891, a high-risk neuroblastoma study in which patients were randomly assigned to undergo autologous purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent treatment with 13-cis-retinoic acid (cis-RA).  Patients and Methods: Patients received the same induction chemotherapy, with random assignment (N = 379) to consolidation with myeloablative chemotherapy, total-body irradn., and ABMT vs. three cycles of intensive chemotherapy.  Patients who completed consolidation without disease progression were randomly assigned to receive no further therapy or cis-RA for 6 mo.  Results: The event-free survival (EFS) for patients randomly assigned to ABMT was significantly higher than those randomly assigned to chemotherapy; the 5-yr EFS (mean ± SE) was 30% ± 4% vs. 19% ± 3%, resp. (P = .04).  The 5-yr EFS (42% ± 5% v 31% ± 5%) from the time of second random assignment was higher for cis-RA than for no further therapy, though it was not significant.  Overall survival (OS) was significantly higher for each random assignment by a test of the log(-log(.)) transformation of the survival ests. at 5 years (P < .01).  The 5-yr OS from the second random assignment of patients who underwent both random assignments and who were assigned to ABMT/cis-RA was 59% ± 8%; for ABMT/no cis-RA, it was 41% ± 7%; for continuing chemotherapy/cis-RA, it was 38% ± 7%; and for chemotherapy/no cis-RA, it was 36% ± 7%.  Conclusion: Myeloablative therapy and autologous hematopoietic cell rescue result in significantly better 5-yr EFS and OS than nonmyeloablative chemotherapy; cis-RA given after consolidation independently results in significantly improved OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTs60W7g6F7Vg90H21EOLACvtfcHk0lgX58BwDW2rdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVCjurY%253D&md5=8d27039287a98633d5daf21555217186</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.13.8925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.13.8925%26sid%3Dliteratum%253Aachs%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DSeeger%26aufirst%3DR.%2BC.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DAdkins%26aufirst%3DE.%2BS.%26aulast%3DHaas-Kogan%26aufirst%3DD.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DVillablanca%26aufirst%3DJ.%2BG.%26atitle%3DLong-term%2520results%2520for%2520children%2520with%2520high-risk%2520neuroblastoma%2520treated%2520on%2520a%2520randomized%2520trial%2520of%2520myeloablative%2520therapy%2520followed%2520by%252013-cis-retinoic%2520acid%253A%2520A%2520children%2527s%2520oncology%2520group%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D1007%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mills, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, R.</span><span> </span><span class="NLM_article-title">Adverse reactions to oral retinoids</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.2165%2F00002018-199309040-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8260121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fot12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1993&pages=280-290&author=C.+M.+Millsauthor=R.+Marks&title=Adverse+reactions+to+oral+retinoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse reactions to oral retinoids. An update</span></div><div class="casAuthors">Mills C M; Marks R</div><div class="citationInfo"><span class="NLM_cas:title">Drug safety</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">280-90</span>
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    </div><div class="casAbstract">Retinoids, both naturally occurring and synthetic, are analogues of vitamin A.  They represent a major advance in the treatment of acne and psoriasis, as well as rarer conditions such as the ichthyoses.  The more frequent and widespread use of these drugs requires that the dermatologist be aware of the wide spectrum of adverse events that may be encountered with their use.  Some are serious and irreversible, such as teratogenicity, necessitating great care if these drugs are given to women of childbearing potential.  Other effects may be less severe, dose dependent and reversible.  Although not devastating to the patient, appropriate advice may reduce morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPc4E2NTx3p-kdrW1FkXG-fW6udTcc2eZAbtM5nqfbCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fot12ksA%253D%253D&md5=5ebbca0af4632a2d451fcb2de674a5c6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F00002018-199309040-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199309040-00006%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DR.%26atitle%3DAdverse%2520reactions%2520to%2520oral%2520retinoids%26jtitle%3DDrug%2520Saf.%26date%3D1993%26volume%3D9%26spage%3D280%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Collins, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G. E.</span><span> </span><span class="NLM_article-title">Teratology of retinoids</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=399-430&author=M.+D.+Collinsauthor=G.+E.+Mao&title=Teratology+of+retinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DM.%2BD.%26aulast%3DMao%26aufirst%3DG.%2BE.%26atitle%3DTeratology%2520of%2520retinoids%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1999%26volume%3D39%26spage%3D399%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">White, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baetz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett-Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonasoro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilworth, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petkovich, M.</span><span> </span><span class="NLM_article-title">Identification of the retinoic acid-inducible all-<i>trans-</i>retinoic acid 4-hydroxylase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">29922</span><span class="NLM_x">–</span> <span class="NLM_lpage">29927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=29922-29927&author=J.+A.+Whiteauthor=Y.-D.+Guoauthor=K.+Baetzauthor=B.+Beckett-Jonesauthor=J.+Bonasoroauthor=K.+E.+Hsuauthor=F.+J.+Dilworthauthor=G.+Jonesauthor=M.+Petkovich&title=Identification+of+the+retinoic+acid-inducible+all-trans-retinoic+acid+4-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BA.%26aulast%3DGuo%26aufirst%3DY.-D.%26aulast%3DBaetz%26aufirst%3DK.%26aulast%3DBeckett-Jones%26aufirst%3DB.%26aulast%3DBonasoro%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DK.%2BE.%26aulast%3DDilworth%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DPetkovich%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520retinoic%2520acid-inducible%2520all-trans-retinoic%2520acid%25204-hydroxylase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D29922%26epage%3D29927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Steensel, M. A. M.</span><span> </span><span class="NLM_article-title">Retinoic acid metabolism blocking agents (RAMBAs): A new paradigm in the treatment of hyperkeratotic disorders</span> <span class="citation_source-journal">J. Dtsch. Dermatol. Ges.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1610-0387.2007.06541.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17941881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD1c3otFOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=355-365&author=C.+J.+Verfailleauthor=M.+Borgersauthor=M.+A.+M.+van+Steensel&title=Retinoic+acid+metabolism+blocking+agents+%28RAMBAs%29%3A+A+new+paradigm+in+the+treatment+of+hyperkeratotic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders</span></div><div class="casAuthors">Verfaille Christel J; Borgers Marcel; van Steensel Maurice A M</div><div class="citationInfo"><span class="NLM_cas:title">Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Synthetic vitamin A derivatives, retinoids,have long been the mainstay of treatment for several disorders of keratinization, notably the ichthyoses and severe acne.  Some forms of psoriasis also respond well.  Their considerable power comes at a price.  They have dose-limiting side effects and can be highly teratogenic, limiting their use in women of childbearing age.Thus, retinoids are used less often than their potential would warrant.  However, the recent development of compounds that block the catabolism of endogenous vitamin A, called Retinioic Acid Metabolism Blocking Agents or RAMBAs, offers new possibilities.  With these drugs, retinoid effects with less side effects and a reduction of the post-treatment teratogenicity period due to their favourable pharmacokinetic profile might be expected.  In this review, we discuss how retinoids work, how they are metabolized and how RAMBAs influence this process.  We also review the presently available data from clinical trials with RAMBAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3Z9_0N61oRoYPsCkJIw00fW6udTcc2eZAbtM5nqfbCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3otFOrtA%253D%253D&md5=34bfad7a80bac05641363ab7e184ca9b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1610-0387.2007.06541.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1610-0387.2007.06541.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3Dvan%2BSteensel%26aufirst%3DM.%2BA.%2BM.%26atitle%3DRetinoic%2520acid%2520metabolism%2520blocking%2520agents%2520%2528RAMBAs%2529%253A%2520A%2520new%2520paradigm%2520in%2520the%2520treatment%2520of%2520hyperkeratotic%2520disorders%26jtitle%3DJ.%2520Dtsch.%2520Dermatol.%2520Ges.%26date%3D2008%26volume%3D6%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Njar, V. C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gediya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purushottamachar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasaitis, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belosay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span> </span><span class="NLM_article-title">Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4323</span><span class="NLM_x">–</span> <span class="NLM_lpage">4340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4323-4340&author=V.+C.+O.+Njarauthor=L.+Gediyaauthor=P.+Purushottamacharauthor=P.+Chopraauthor=T.+S.+Vasaitisauthor=A.+Khandelwalauthor=J.+Mehtaauthor=C.+Huynhauthor=A.+Belosayauthor=J.+Patel&title=Retinoic+acid+metabolism+blocking+agents+%28RAMBAs%29+for+treatment+of+cancer+and+dermatological+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNjar%26aufirst%3DV.%2BC.%2BO.%26aulast%3DGediya%26aufirst%3DL.%26aulast%3DPurushottamachar%26aufirst%3DP.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DVasaitis%26aufirst%3DT.%2BS.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DJ.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DBelosay%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%26atitle%3DRetinoic%2520acid%2520metabolism%2520blocking%2520agents%2520%2528RAMBAs%2529%2520for%2520treatment%2520of%2520cancer%2520and%2520dermatological%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4323%26epage%3D4340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchet-Bardon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Steensel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steijlen, P. M.</span><span> </span><span class="NLM_article-title">Oral liarozole vs. acitretin in the treatment of ichthyosis: A phase II/III multicentre, double-blind, randomized, active-controlled study</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2133.2006.07745.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17263800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt12rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2007&pages=965-973&author=C.+J.+Verfailleauthor=F.+P.+Vanhoutteauthor=C.+Blanchet-Bardonauthor=M.+A.+van+Steenselauthor=P.+M.+Steijlen&title=Oral+liarozole+vs.+acitretin+in+the+treatment+of+ichthyosis%3A+A+phase+II%2FIII+multicentre%2C+double-blind%2C+randomized%2C+active-controlled+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study</span></div><div class="casAuthors">Verfaille, C. J.; Vanhoutte, F. P.; Blanchet-Bardon, C.; van Steense, M. A.; Steijlen, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">965-973</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Liarozole, a retinoic acid metab. blocking agent, has been granted orphan drug status for congenital ichthyosis by the European Commission and the U.S. Food and Drug Administration.  The purpose of this trial was to investigate the efficacy, tolerability and safety of oral liarozole vs. acitretin in patients with ichthyosis.  In this double-blind comparative trial of liarozole vs. acitretin, 32 patients with ichthyosis were randomized to be treated with either oral liarozole 75 mg in the morning and 75 mg in the evening or with acitretin 10 mg in the morning and 25 mg in the evening for 12 wk.  Clin. efficacy, tolerability and safety were monitored.  Between-group comparisons for efficacy and tolerability revealed no statistically significant differences except for scaling on the trunk at baseline which was significantly worse in the liarozole group (P = 0.024) and showed a more pronounced improvement in this group than in the acitretin-treated patients (P = 0.047).  Based on the overall evaluation of the response to treatment at end-point, 10 of 15 patients in the liarozole group and 13 of 16 patients in the acitretin group were considered by the investigator to be at least markedly improved.  The expected retinoic acid-related adverse events were mostly mild to moderate and tended to occur less frequently in the liarozole group.  No serious adverse events related to the drugs occurred.  The present study indicates that liarozole at a daily dose of 150 mg is equally effective as a treatment for ichthyosis as acitretin but shows a trend towards a more favorable tolerability profile.  The results of this trial warrant further clin. trials to confirm efficacy and safety of liarozole as an orphan drug in ichthyosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryTSUlmtVyWLVg90H21EOLACvtfcHk0lhFkp3DnzgHGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt12rtrY%253D&md5=b20f5eeefc5284587e989c9cfda718da</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2006.07745.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2006.07745.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DVanhoutte%26aufirst%3DF.%2BP.%26aulast%3DBlanchet-Bardon%26aufirst%3DC.%26aulast%3Dvan%2BSteensel%26aufirst%3DM.%2BA.%26aulast%3DSteijlen%26aufirst%3DP.%2BM.%26atitle%3DOral%2520liarozole%2520vs.%2520acitretin%2520in%2520the%2520treatment%2520of%2520ichthyosis%253A%2520A%2520phase%2520II%252FIII%2520multicentre%252C%2520double-blind%252C%2520randomized%252C%2520active-controlled%2520study%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D156%26spage%3D965%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bryson, H. M.; Wagstaff, A. J.</span><span> </span><span class="NLM_article-title">Liarozole</span>.  <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">478484</span>, discussion 485.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.2165%2F00002512-199609060-00010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=478484&author=H.+M.+Bryson&author=A.+J.+Wagstaff&title=Liarozole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2165%2F00002512-199609060-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199609060-00010%26sid%3Dliteratum%253Aachs%26aulast%3DBryson%26aufirst%3DH.%2BM.%26atitle%3DLiarozole%26jtitle%3DDrugs%2520Aging%26date%3D1996%26volume%3D9%26spage%3D478484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thissen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bovenschen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiljen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Kerkhof, P. C. M.</span><span> </span><span class="NLM_article-title">Oral R115866 in the treatment of moderate to severe plaque-type psoriasis</span> <span class="citation_source-journal">J. Eur. Acad. Dermatol. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1468-3083.2007.02158.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17714122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A280%3ADC%252BD2svpsFeqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=1038-1046&author=C.+J.+Verfailleauthor=C.+A.+Thissenauthor=H.+J.+Bovenschenauthor=J.+Mertensauthor=P.+M.+Steiljenauthor=P.+C.+M.+van+de+Kerkhof&title=Oral+R115866+in+the+treatment+of+moderate+to+severe+plaque-type+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oral R115866 in the treatment of moderate to severe plaque-type psoriasis</span></div><div class="casAuthors">Verfaille C J; Thissen C A C B; Bovenschen H J; Mertens J; Steijlen P M; van de Kerkhof P C M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology : JEADV</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1038-46</span>
        ISSN:<span class="NLM_cas:issn">0926-9959</span>.
    </div><div class="casAbstract">BACKGROUND:  R115866 (Rambazole) is a new generation all-trans retinoic acid metabolism blocking agent, highly specific against the retinoic acid 4-hydroxylase.  The drug alleviates hyperproliferation and normalizes differentiation of the epidermis in animal models of psoriasis.  OBJECTIVE:  To explore the efficacy, safety and tolerability of systemic R115866 in patients with moderate to severe plaque-type psoriasis.  PATIENTS AND METHODS:  In this open label, single-arm trial, patients were treated with R115866, 1 mg/day for 8 weeks, followed by a 2-week treatment-free follow-up period.  Patients were monitored for efficacy and safety.  RESULTS:  Nineteen patients (intent-to-treat population) were treated and 14 completed the entire study.  Two patients discontinued due to lack of efficacy and three due to adverse events.  At the end of the treatment, 26% of the patients showed at least 50% reduction in Psoriasis Area Severity Index (PASI) compared to baseline.  Further improvement was observed at the end of the 2-week follow-up period where 47% of the patients showed a 50% or greater reduction in PASI.  Kinetic data showed no evidence of accumulation of either R115866 or retinoic acid in plasma.  The most common adverse events were pruritus, xerosis, cheilitis and an increase in blood triglycerides.  The majority of adverse events were mild to moderate.  No deaths or serious adverse events were reported.  CONCLUSION:  Eight-week daily treatment with 1 mg R115866 resulted in a significant reduction in PASI from baseline to end of therapy.  Additional improvement was seen after the 2-week follow-up period.  The drug was well tolerated.  R115866 merits further evaluation to optimize its clinical efficacy and safety profile in moderate to severe plaque-type psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu-YGceVFf4CnGiHuhFGv8fW6udTcc2ebizgAoLbxkPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpsFeqtg%253D%253D&md5=f0ede2958be29ce134445e86bcd2f711</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2007.02158.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2007.02158.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DThissen%26aufirst%3DC.%2BA.%26aulast%3DBovenschen%26aufirst%3DH.%2BJ.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DSteiljen%26aufirst%3DP.%2BM.%26aulast%3Dvan%2Bde%2BKerkhof%26aufirst%3DP.%2BC.%2BM.%26atitle%3DOral%2520R115866%2520in%2520the%2520treatment%2520of%2520moderate%2520to%2520severe%2520plaque-type%2520psoriasis%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2007%26volume%3D21%26spage%3D1038%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Verfaille, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roseeuw, D.</span><span> </span><span class="NLM_article-title">Oral R115866 in the treatment of moderate to severe facial acne vulgaris: An exploratory study</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1111%2Fj.1365-2133.2007.07896.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17459036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovVOmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2007&pages=122-126&author=C.+J.+Verfailleauthor=M.+Coelauthor=I.+H.+Boersmaauthor=J.+Mertensauthor=M.+Borgersauthor=D.+Roseeuw&title=Oral+R115866+in+the+treatment+of+moderate+to+severe+facial+acne+vulgaris%3A+An+exploratory+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study</span></div><div class="casAuthors">Verfaille, C. J.; Coel, M.; Boersma, I. H.; Mertens, J.; Borgers, M.; Roseeuw, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-126</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: R115866 (Rambazole; barrier Therapeutics NV, Geel, Belgium), a new-generation retinoic acid metab.-blocking agent, is a nonretinoid compd. enhancing intracellularly the endogenous levels of all-trans-retinoic acid by blocking its catabolism.  By virtue of this property, and the proven pos. effects of retinoids in the treatment of acne, R115866 could potentially be a useful drug for acne.  Objectives: To explore the efficacy, safety and tolerability of systemic R115866 in male patients with moderate to severe facial acne vulgaris (at least 15 papules and/or pustules and at least two nodulocystic lesions).  Methods: In this exploratory trial, 17 patients were treated with oral R115866 1 mg once daily for 12 wk, followed by a 4-wk treatment-free period.  Results: At the end of treatment (week 12, n = 16) a mean redn. in inflammatory lesion count of 77·4% (P < 0·001), in noninflammatory lesion count of 58·3% (P < 0·001) and in total lesion count of 76·0% (P < 0·001) was obsd. as compared with baseline.  All lesion counts were significantly reduced from week 4 onwards.  Mild side-effects were reported occasionally.  Conclusions: The current data indicate that treatment with oral R115866 1 mg once daily for 12 wk in patients with moderate to severe facial acne vulgaris is efficacious and well tolerated and merits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGR6PycNmm4LVg90H21EOLACvtfcHk0lgU7vRD0-SN3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovVOmtLg%253D&md5=4fa0aa460f2405f4e376159991083ab4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2007.07896.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2007.07896.x%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaille%26aufirst%3DC.%2BJ.%26aulast%3DCoel%26aufirst%3DM.%26aulast%3DBoersma%26aufirst%3DI.%2BH.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DRoseeuw%26aufirst%3DD.%26atitle%3DOral%2520R115866%2520in%2520the%2520treatment%2520of%2520moderate%2520to%2520severe%2520facial%2520acne%2520vulgaris%253A%2520An%2520exploratory%2520study%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D157%26spage%3D122%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Geria, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinfeld, N. S.</span><span> </span><span class="NLM_article-title">Talarazole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1228-1237&author=A.+N.+Geriaauthor=N.+S.+Scheinfeld&title=Talarazole%2C+a+selective+inhibitor+of+P450-mediated+all-trans+retinoic+acid+for+the+treatment+of+psoriasis+and+acne"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeria%26aufirst%3DA.%2BN.%26aulast%3DScheinfeld%26aufirst%3DN.%2BS.%26atitle%3DTalarazole%252C%2520a%2520selective%2520inhibitor%2520of%2520P450-mediated%2520all-trans%2520retinoic%2520acid%2520for%2520the%2520treatment%2520of%2520psoriasis%2520and%2520acne%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D9%26spage%3D1228%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Van Heusden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ginckel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruwiere, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelans, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Leede, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hove, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, W.</span><span> </span><span class="NLM_article-title">Inhibition of all-<i>trans</i>-retinoic acid metabolism by R116010 induces antitumour activity</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1038%2Fsj.bjc.6600056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=11870544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD38XislCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=605-611&author=J.+Van+Heusdenauthor=R.+Van+Ginckelauthor=H.+Bruwiereauthor=P.+Moelansauthor=B.+Janssenauthor=W.+Florenauthor=B.+J.+van+der+Leedeauthor=J.+van+Dunauthor=G.+Sanzauthor=M.+Venetauthor=L.+Dillenauthor=C.+Van+Hoveauthor=G.+Willemsensauthor=M.+Janicotauthor=W.+Wouters&title=Inhibition+of+all-trans-retinoic+acid+metabolism+by+R116010+induces+antitumour+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumor activity</span></div><div class="casAuthors">Van Heusden, J.; Van Ginckel, R.; Bruwiere, H.; Moelans, P.; Janssen, B.; Floren, W.; van der Leede, B. J.; van Dun, J.; Sanz, G.; Venet, M.; Dillen, L.; Van Hove, C.; Willemsens, G.; Janicot, M.; Wouters, W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">All-trans-retinoic acid is a potent inhibitor of cell proliferation and inducer of differentiation.  However, the clin. use of all-trans-retinoic acid in the treatment of cancer is significantly hampered by its toxicity and the prompt emergence of resistance, believed to be caused by increased all-trans-retinoic acid metab.  Inhibitors of all-trans-retinoic acid metab. may therefore prove valuable in the treatment of cancer.  In this study, we characterize R116010 as a new anticancer drug that is a potent inhibitor of all-trans-retinoic acid metab.  In vitro, R116010 potently inhibits all-trans-retinoic acid metab. in intact T47D cells with an IC50-value of 8.7 nM.  In addn., R116010 is a selective inhibitor as indicated by its inhibition profile for several other cytochrome P 450-mediated reactions.  In T47D cell proliferation assays, R116010 by itself has no effect on cell proliferation.  However, in combination with all-trans-retinoic acid, R116010 enhances the all-trans-retinoic acid-mediated antiproliferative activity in a concn.-dependent manner.  In vivo, the growth of murine estrogen-independent TA3-Ha mammary tumors is significantly inhibited by R116010 at doses as low as 0.16 mg kg-1.  In conclusion, R116010 is a highly potent and selective inhibitor of all-trans-retinoic acid metab., which is able to enhance the biol. activity of all-trans-retinoic acid, thereby exhibiting antitumor activity.  R116010 represents a novel and promising anticancer drug with an unique mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcR0XArGxYm7Vg90H21EOLACvtfcHk0lgU7vRD0-SN3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislCmt7o%253D&md5=b34c02fa359e61af9ad63b6e5a6a52c1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600056%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHeusden%26aufirst%3DJ.%26aulast%3DVan%2BGinckel%26aufirst%3DR.%26aulast%3DBruwiere%26aufirst%3DH.%26aulast%3DMoelans%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DB.%26aulast%3DFloren%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BLeede%26aufirst%3DB.%2BJ.%26aulast%3Dvan%2BDun%26aufirst%3DJ.%26aulast%3DSanz%26aufirst%3DG.%26aulast%3DVenet%26aufirst%3DM.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DVan%2BHove%26aufirst%3DC.%26aulast%3DWillemsens%26aufirst%3DG.%26aulast%3DJanicot%26aufirst%3DM.%26aulast%3DWouters%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520all-trans-retinoic%2520acid%2520metabolism%2520by%2520R116010%2520induces%2520antitumour%2520activity%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D605%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span> </span><span class="NLM_article-title">Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1038%2Fsj.bjc.6603779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17486130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1675-1683&author=J.+L.+Armstrongauthor=A.+V.+Boddyauthor=C.+P.+F.+Redfernauthor=G.+J.+Veal&title=Molecular+targeting+of+retinoic+acid+metabolism+in+neuroblastoma%3A+the+role+of+the+CYP26+inhibitor+R116010+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targeting of retinoic acid metabolism in neuroblastoma: The role of the CYP26 inhibitor R116010 in vitro and in vivo</span></div><div class="casAuthors">Armstrong, J. L.; Taylor, G. A.; Thomas, H. D.; Boddy, A. V.; Redfern, C. P. F.; Veal, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1675-1683</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Isomerization to all-trans-retinoic acid (ATRA) is widely accepted as the key mechanism underlying the favorable clin. properties of 13-cis-retinoic acid (13cisRA).  As intracellular metab. of ATRA by CYP26 may result in clin. resistance to 13cisRA, an increase in efficacy may be achieved through modulation of this metabolic pathway.  We have evaluated the effect of the CYP26 inhibitor R116010 on retinoid metab. in neuroblastoma cell lines and a xenograft model.  In neuroblastoma cells, which showed a high level of CYP26 induction in response to ATRA, R116010 selectively inhibited ATRA metab.  In addn., siRNA-mediated knockdown of CYP26 selectively increased ATRA levels and the expression of retinoid-responsive marker genes was potentiated by R116010.  Treatment of mice bearing SH-SY5Y xenografts with 13cisRA (100 mg kg-1) revealed substantial levels (16%) of intratumoral ATRA after 6 h, despite plasma ATRA levels representing only 1% total retinoids under these conditions.  Co-administration of R116010 with 13cisRA in this mouse model resulted in significant increases in plasma ATRA and 13cisRA concns.  Furthermore, R116010 induced significant decreases in levels of 4-oxo metabolites in hepatic tissue after co-administration with either ATRA or 13cisRA.  These data suggest considerable potential for CYP26 inhibitors in the future treatment of neuroblastoma with 13cisRA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKjfql9mzZRrVg90H21EOLACvtfcHk0lj8R9G96tlnJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVShsbc%253D&md5=d8a5e451095172659c6c534d42d8ec2d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603779%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DBoddy%26aufirst%3DA.%2BV.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26atitle%3DMolecular%2520targeting%2520of%2520retinoic%2520acid%2520metabolism%2520in%2520neuroblastoma%253A%2520the%2520role%2520of%2520the%2520CYP26%2520inhibitor%2520R116010%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1675%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgens, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboraia, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): Synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101583w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2778-2791&author=M.+S.+Gomaaauthor=C.+E.+Bridgensauthor=A.+S.+Aboraiaauthor=G.+J.+Vealauthor=C.+P.+F.+Redfernauthor=A.+Brancaleauthor=J.+L.+Armstrongauthor=C.+Simons&title=Small+molecule+inhibitors+of+retinoic+acid+4-hydroxylase+%28CYP26%29%3A+Synthesis+and+biological+evaluation+of+imidazole+methyl+3-%284-%28aryl-2-ylamino%29phenyl%29propanoates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm101583w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101583w%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DBridgens%26aufirst%3DC.%2BE.%26aulast%3DAboraia%26aufirst%3DA.%2BS.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520retinoic%2520acid%25204-hydroxylase%2520%2528CYP26%2529%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520imidazole%2520methyl%25203-%25284-%2528aryl-2-ylamino%2529phenyl%2529propanoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2778%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobillon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-<i>trans</i> retinoic acid activity in neuroblastoma cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8301</span><span class="NLM_x">–</span> <span class="NLM_lpage">8313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8301-8313&author=M.+S.+Gomaaauthor=J.+L.+Armstrongauthor=B.+Bobillonauthor=G.+J.+Vealauthor=A.+Brancaleauthor=C.+P.+F.+Redfernauthor=C.+Simons&title=Novel+azolyl-%28phenylmethyl%29%5Daryl%2Fheteroarylamines%3A+Potent+CYP26+inhibitors+and+enhancers+of+all-trans+retinoic+acid+activity+in+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DBobillon%26aufirst%3DB.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%2BF.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DNovel%2520azolyl-%2528phenylmethyl%2529%255Daryl%252Fheteroarylamines%253A%2520Potent%2520CYP26%2520inhibitors%2520and%2520enhancers%2520of%2520all-trans%2520retinoic%2520acid%2520activity%2520in%2520neuroblastoma%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8301%26epage%3D8313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Keyser, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cock, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span> </span><span class="NLM_article-title">A versatile and convenient multigram syntheis of methylidenemalonic acid diesters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4859</span><span class="NLM_x">–</span> <span class="NLM_lpage">4862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=4859-4862&author=J.+L.+Keyserauthor=C.+J.+De+Cockauthor=J.+H.+Poupaertauthor=P.+Dumont&title=A+versatile+and+convenient+multigram+syntheis+of+methylidenemalonic+acid+diesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeyser%26aufirst%3DJ.%2BL.%26aulast%3DDe%2BCock%26aufirst%3DC.%2BJ.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DDumont%26aufirst%3DP.%26atitle%3DA%2520versatile%2520and%2520convenient%2520multigram%2520syntheis%2520of%2520methylidenemalonic%2520acid%2520diesters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D4859%26epage%3D4862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bender, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol702892e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=509-511&author=D.+M.+Benderauthor=J.+A.+Petersonauthor=J.+R.+McCarthyauthor=H.+Gunaydinauthor=Y.+Takanoauthor=K.+N.+Houk&title=Cyclopropanecarboxylic+acid+esters+as+potential+prodrugs+with+enhanced+hydrolytic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fol702892e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol702892e%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DD.%2BM.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DCyclopropanecarboxylic%2520acid%2520esters%2520as%2520potential%2520prodrugs%2520with%2520enhanced%2520hydrolytic%2520stability%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D509%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paternak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicario, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascieri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span> </span><span class="NLM_article-title">Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070166b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2609-2611&author=L.+Yangauthor=G.+Butoraauthor=R.+X.+Jiaoauthor=A.+Paternakauthor=C.+Zhouauthor=W.+H.+Parsonsauthor=S.+G.+Millsauthor=P.+P.+Vicarioauthor=J.+M.+Ayalaauthor=M.+A.+Cascieriauthor=M.+Maccoss&title=Discovery+of+3-piperidinyl-1-cyclopentanecarboxamide+as+a+novel+scaffold+for+highly+potent+CC+chemokine+receptor+2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm070166b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070166b%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DButora%26aufirst%3DG.%26aulast%3DJiao%26aufirst%3DR.%2BX.%26aulast%3DPaternak%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DVicario%26aufirst%3DP.%2BP.%26aulast%3DAyala%26aufirst%3DJ.%2BM.%26aulast%3DCascieri%26aufirst%3DM.%2BA.%26aulast%3DMaccoss%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25203-piperidinyl-1-cyclopentanecarboxamide%2520as%2520a%2520novel%2520scaffold%2520for%2520highly%2520potent%2520CC%2520chemokine%2520receptor%25202%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2609%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Keliher, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobanian, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conkrite, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span> </span><span class="NLM_article-title">Efficient syntheses of four stable-isotope labeled (1<i>R</i>)-menthyl (1<i>S</i>,2<i>S</i>)-(+)-2-phenylcyclopropanecarboxylates</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=2777-2784&author=E.+J.+Keliherauthor=R.+C.+Burrellauthor=H.+R.+Chobanianauthor=K.+L.+Conkriteauthor=R.+Shuklaauthor=J.+E.+Baldwin&title=Efficient+syntheses+of+four+stable-isotope+labeled+%281R%29-menthyl+%281S%2C2S%29-%28%2B%29-2-phenylcyclopropanecarboxylates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeliher%26aufirst%3DE.%2BJ.%26aulast%3DBurrell%26aufirst%3DR.%2BC.%26aulast%3DChobanian%26aufirst%3DH.%2BR.%26aulast%3DConkrite%26aufirst%3DK.%2BL.%26aulast%3DShukla%26aufirst%3DR.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26atitle%3DEfficient%2520syntheses%2520of%2520four%2520stable-isotope%2520labeled%2520%25281R%2529-menthyl%2520%25281S%252C2S%2529-%2528%252B%2529-2-phenylcyclopropanecarboxylates%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D2777%26epage%3D2784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mattsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, S.</span><span> </span><span class="NLM_article-title">A mild hydrolysis of esters mediated by lithium salts</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2497</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2Fj.tetlet.2007.02.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2497-2499&author=S.+Mattssonauthor=M.+Dahlstromauthor=S.+Karlsson&title=A+mild+hydrolysis+of+esters+mediated+by+lithium+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A mild hydrolysis of esters mediated by lithium salts</span></div><div class="casAuthors">Mattsson, Sara; Dahlstroem, Mikael; Karlsson, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2497-2499</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">When treated with amine bases such as triethylamine and various lithium salts in wet solvents, esters are efficiently hydrolyzed to the corresponding acids in good yields.  Esters incorporating an α- or β-heteroatom with respect to the ester carbonyl group are hydrolyzed rapidly even at room temp.  To further demonstrate the usefulness of this method, one example is provided where hydrolysis of acetylated camphorsultam is mediated by LiBr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdhTIjsx0bVg90H21EOLACvtfcHk0liR2s_A4asHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D&md5=7a88787176f93ccdd555a0ab411b0635</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DS.%26aulast%3DDahlstrom%26aufirst%3DM.%26aulast%3DKarlsson%26aufirst%3DS.%26atitle%3DA%2520mild%2520hydrolysis%2520of%2520esters%2520mediated%2520by%2520lithium%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2497%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Han, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span> </span><span class="NLM_article-title">Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2069</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1210%2Fjc.81.6.2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8964830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK28XjsFyksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=2069-2075&author=I.+S.+Hanauthor=J.+H.+Choi&title=Highly+specific+cytochrome+P450-like+enzymes+for+all-trans-retinoic+acid+in+T47D+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells</span></div><div class="casAuthors">Han, In Suk; Choi, Jee-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2069-2075</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">When human breast cancer T47D cells were treated with all-trans-retinoic acid (RA), the RA 4- and 18-hydroxylase activities were induced in microsomes in a time-dependent manner, indicating that these cells readily metabolized RA into more polar compds., such as all-trans-4-hydroxy-RA and all-trans-18-hydroxy-RA.  In contrast, T47D cells treated for 12 h with xenobiotics, such as phenobarbital, β-naphthoflavone, 3-methylcholanthrene, and DMSO, showed lower levels of catalytic activities for 4- and 18-hydroxylases.  The induction of 4- and 18-hydroxylase activities appears to be regulated at the level of transcriptional control (basal level).  Competitive assays demonstrated that inhibitors and substrates for 1A, 2A, 3A, 2B, and 2C cytochrome P 450 (P 450 subfamilies), all-trans-retinol, and all-trans-retinal showed no inhibition of RA metab., but other retinoic acid derivs. competed highly with RA.  The RA-inducible 4- and 18-hydroxylases showed high specificity for RA and high levels of catalytic activities, with Km and max. velocity values for 4-hydroxylase equal to 99 nmol/L and 0.26 pmol/min·mg protein, resp., and those for 18-hydroxylase equal to 65 nmol/L and 0.18 pmol/min·mg protein.  Cell-free metab. of RA required microsomes from RA-treated cells and NADPH, and was inhibited by liarozole, an inhibitor of P 450.  These data suggest that RA-inducible 4- and 18-hydroxylases may be novel P 450 isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod6bx0AQ05JbVg90H21EOLACvtfcHk0liR2s_A4asHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFyksr8%253D&md5=6532f8828e33fd4448002da0b3b3b147</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1210%2Fjc.81.6.2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.81.6.2069%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DI.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26atitle%3DHighly%2520specific%2520cytochrome%2520P450-like%2520enzymes%2520for%2520all-trans-retinoic%2520acid%2520in%2520T47D%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1996%26volume%3D81%26spage%3D2069%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span> </span><span class="NLM_article-title">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1124%2Fdmd.105.004259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=15932954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1304-1311&author=R.+J.+Rileyauthor=D.+F.+McGinnityauthor=R.+P.+Austin&title=A+unified+model+for+predicting+human+hepatic%2C+metabolic+clearance+from+in+vitro+intrinsic+clearance+data+in+hepatocytes+and+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes</span></div><div class="casAuthors">Riley, Robert J.; McGinnity, D. F.; Austin, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1304-1311</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate a unified method for predicting human in vivo intrinsic clearance (CLint, in vivo) and hepatic clearance (CLh) from in vitro data in hepatocytes and microsomes by applying the unbound fraction in blood (fub) and in vitro incubations (fuinc).  Human CLint, in vivo was projected using in vitro data together with biol. scaling factors and compared with the unbound intrinsic clearance (CLint, ub, in vivo) estd. from clin. data using liver models with and without the various fu terms.  For incubations conducted with fetal calf serum (n = 14), the obsd. CLint, in vivo was modeled well assuming fuinc and fub were equiv.  CLint, ub, in vivo was predicted best using both fub and fuinc for other hepatocyte data (n = 56; r2 = 0.78, p = 3.3×10-19, av. fold error = 5.2).  A similar model for CLint, ub, in vivo was established for microsomal data (n = 37; r2 = 0.77, p = 1.2×10-12, av. fold error = 6.1).  Using the model for CLint, ub, in vivo (including a further empirical scaling factor), the CLh in humans was also calcd. according to the well stirred liver model for the most extensive dataset.  CLint, in vivo and CLh were both predicted well using in vitro human data from several labs. for acidic, basic, and neutral drugs.  The direct use of this model using only in vitro human data to predict the metabolic component of CLh is attractive, as it does not require extra information from preclin. studies in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrU05rRTm6LVg90H21EOLACvtfcHk0liR2s_A4asHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamt74%253D&md5=79b80848977739267e4dd0ae82e5cbab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.004259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.004259%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26atitle%3DA%2520unified%2520model%2520for%2520predicting%2520human%2520hepatic%252C%2520metabolic%2520clearance%2520from%2520in%2520vitro%2520intrinsic%2520clearance%2520data%2520in%2520hepatocytes%2520and%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1304%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbourne, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span> </span><span class="NLM_article-title">Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): Active site architecture and ligand binding</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1080%2F14756360600742014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=17059167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=361-369&author=M.+S.+Gomaaauthor=S.+W.+Yeeauthor=C.+E.+Milbourneauthor=M.+C.+Barberaauthor=C.+Simonsauthor=A.+Brancale&title=Homology+model+of+human+retinoic+acid+metabolising+enzyme+cytochrome+P450+26A1+%28CYP26A1%29%3A+Active+site+architecture+and+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding</span></div><div class="casAuthors">Gomaa, Mohamed Sayed; Yee, Sook Wah; Milbourne, Ceri Elizabeth; Barbera, Maria Chiara; Simons, Claire; Brancale, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-369</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Homol. models of cytochrome P 450 RA1 (CYP26A1) were constructed using three human P 450 structures, CYP2C8, CYP2C9 and CYP3A4 as templates for the model building.  Using MOE software the lowest energy CYP26A1 model was then assessed for stereochem. quality and side chain environment.  Further active site optimization of the CYP26A1 model built using the CYP3A4 template was performed by mol. dynamics to generate a final CYP26A1 model.  The natural substrate, all-trans-retinoic acid (atRA), and inhibitor R115866, were docked into the model allowing further validation of the active site architecture.  Using the docking studies structurally and functionally important residues were identified with subsequent characterization of secondary structure.  Multiple hydrophobic interactions, including the side chains of Trp112, Phe299, Phe222, Phe84, Phe374 and Pro371, are important for binding of atRA and R115866.  Addnl. hydrogen bonding interactions were noted as follows: atRA - C=O of the atRA carboxylate group and Arg86; R115866 - benzothiazole nitrogen and the backbone NH of Ser115.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxHFbWHD55GbVg90H21EOLACvtfcHk0liiv_nYgptU8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbM&md5=7b4c3b0ed018ca842395f2146c313d6e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F14756360600742014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600742014%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DMilbourne%26aufirst%3DC.%2BE.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26aulast%3DSimons%26aufirst%3DC.%26aulast%3DBrancale%26aufirst%3DA.%26atitle%3DHomology%2520model%2520of%2520human%2520retinoic%2520acid%2520metabolising%2520enzyme%2520cytochrome%2520P450%252026A1%2520%2528CYP26A1%2529%253A%2520Active%2520site%2520architecture%2520and%2520ligand%2520binding%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D361%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Perrin, D. D.; Armarengo, W. L. F.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Pergamon Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=D.+D.+Perrin&author=W.+L.+F.+Armarengo&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin%26aufirst%3DD.%2BD.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DPergamon%2520Press%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Molecular Operating Environment 2008.10 (MOE) Chemical Computing Group Inc Montreal Quebec Canada <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+2008.10+%28MOE%29+Chemical+Computing+Group+Inc+Montreal+Quebec+Canada+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stützle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span> <span class="citation_source-journal">Swarm Intell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1007%2Fs11721-007-0006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Korb%2C+O.%3B+St%C3%BCtzle%2C+T.%3B+Exner%2C+T.+E.Swarm+Intell.+2007%2C+1%2C+115%E2%80%93134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs11721-007-0006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11721-007-0006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26jtitle%3DSwarm%2520Intell.%26date%3D2007%26volume%3D1%26spage%3D115%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Spoel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drunen, R.</span><span> </span><span class="NLM_article-title">GROMACS: A message-passing parallel molecular dynamics implementation</span> <span class="citation_source-journal">Comput. Phys. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+van+der+Spoelauthor=R.+van+Drunen&title=GROMACS%3A+A+message-passing+parallel+molecular+dynamics+implementation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="97f0e5f8faf6f4e4d7f4fff2fab9e5e2f0b9f9fb">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0liiv_nYgptU8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3Dvan%2BDrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520A%2520message-passing%2520parallel%2520molecular%2520dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lindahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Spoel, D.</span><span> </span><span class="NLM_article-title">GROMACS 3.0: A package for molecular simulation and trajectory analysis</span> <span class="citation_source-journal">J. Mol. Mod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1007%2Fs008940100045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVGjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=306-317&author=E.+Lindahlauthor=B.+Hessauthor=D.+van+der+Spoel&title=GROMACS+3.0%3A+A+package+for+molecular+simulation+and+trajectory+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 3.0: a package for molecular simulation and trajectory analysis</span></div><div class="casAuthors">Lindahl, Erik; Hess, Berk; van der Spoel, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling [online computer file]</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">GROMACS 3.0 is the latest release of a versatile and very well optimized package for mol. simulation.  Much effort has been devoted to achieving extremely high performance on both workstations and parallel comouters.  The design includes an extn. of virial and periodic boundary conditions from the loops over pairwise interactions, and special software routines to enable rapid calcn. of x-1/2.  Inner loops are generated automatically in C or Fortran at compile time, with optimizations adapted to each architecture.  Assembly loops using SSE and 3DNow! multimedia instructions are provided for x86 processors, resulting in exceptional performance on inexpensive PC workstations.  The interface is simple and easy to use, based on std. command line arguments with self-explanatory functionality and integrated documentation.  A large collection of flexible tools for trajectory anal. is included, with output in the form of finished Xmgr/Grace graphs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xBKmKIYW3bVg90H21EOLACvtfcHk0liiv_nYgptU8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVGjsL4%253D&md5=fca1fafdbbab2f42b3ab9c789b8a048e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs008940100045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs008940100045%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DE.%26aulast%3DHess%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26atitle%3DGROMACS%25203.0%253A%2520A%2520package%2520for%2520molecular%2520simulation%2520and%2520trajectory%2520analysis%26jtitle%3DJ.%2520Mol.%2520Mod.%26date%3D2001%26volume%3D7%26spage%3D306%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Humphrey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">VMD—Visual Molecular Dynamics</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm200695m&amp;key=10.1016%2F0263-7855%2896%2900018-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm200695m&amp;key=8744570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm200695m&amp;key=1%3ACAS%3A528%3ADyaK28Xis12nsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=33-38&author=W.+Humphreyauthor=A.+Dalkeauthor=K.+Schulten&title=VMD%E2%80%94Visual+Molecular+Dynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">VDM: visual molecular dynamics</span></div><div class="casAuthors">Humphrey, William; Dalke, Andrew; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8, plates, 27-28</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">VMD is a mol. graphics program designed for the display and anal. of mol. assemblies, in particular, biopolymers such as proteins and nucleic acids.  VMD can simultaneously display any no. of structures using a wide variety of rendering styles and coloring methods.  Mols. are displayed as one or more "representations," in which each representation embodies a particular rendering method and coloring scheme for a selected subset of atoms.  The atoms displayed in each representation are chosen using an extensive atom selection syntax, which includes Boolean operators and regular expressions.  VMD provides a complete graphical user interface for program control, as well as a text interface using the Tcl embeddable parser to allow for complex scripts with variable substitution, control loops, and function calls.  Full session logging is supported, which produces a VMD command script for later playback.  High-resoln. raster images of displayed mols. may be produced by generating input scripts for use by a no. of photorealistic image-rendering applications.  VMD has also been expressly designed with the ability to animate mol. dynamics (MD) simulation trajectories, imported either from files or from a direct connection to a running MD simulation.  VMD is the visualization component of MDScope, a set of tools for interactive problem solving in structural biol., which also includes the parallel MD program NAMD, and the MDCOMM software used to connect the visualization and simulation programs, VMD is written in C++, using an object-oriented design; the program, including source code and extensive documentation, is freely available via anonymous ftp and through the World Wide Web.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dd54QvBO97Vg90H21EOLACvtfcHk0lgpH2ABOIpRdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis12nsrg%253D&md5=1e3094ec3151fb85c5ff05f8505c78d5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2896%2900018-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252896%252900018-5%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DW.%26aulast%3DDalke%26aufirst%3DA.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DVMD%25E2%2580%2594Visual%2520Molecular%2520Dynamics%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1996%26volume%3D14%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm200695m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42158"></div></div></div></div></div><hr /></hr><p class="last">Numbering of compounds for <sup>1</sup>H and <sup>13</sup>C NMR characterization and <sup>13</sup>C NMR spectroscopic data for compounds <b>4</b>– <b>12</b>, <b>15</b>, and <b>17</b>–<b>19</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200695m/suppl_file/jm200695m_si_001.pdf">jm200695m_si_001.pdf (140.31 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200695m&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm200695m%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200695m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a35806c2124fd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
